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TMAO trimethylamine N-oxide 
TMS trimethylsilyl 
UV ultraviolet 
 
 vii 
ACKNOWLEDGMENTS 
 
 I would like to express my sincere gratitude to Professor George A. Kraus for his 
generous support and encouragement through out my graduate education. It is a great 
honor to pursue a Ph.D. degree under his supervision. In the last five years, the consistent 
guidance and great opportunities he provided not only helped me succeed as a graduate 
student, but also prepared me to move onto the next stage of my career as a scientist. I 
will always remember his expertise and passion in organic synesthetic chemistry. 
In addition, I would like to thank my program of study committee members: 
Professors Susan Carpenter, Levi Stanley, Keith Woo and Yan Zhao for their guidance 
and helpful suggestions. I really appreciate all the support from Prof. Yan Zhao during 
the early stage of my career. I would also like to thank for our research collaborators: 
Professor Susan Carpenter and Alyssa Evans at Iowa State University, Professors Abhaya 
Datye, and Hien Pham at University of New Mexico. 
I am grateful to work with all former and current Kraus group members. I would 
thank Drs. Tezcan Guney, Jenny Lee, and Gerald Pollock III for their suggestions and 
training to develop my skills. I appreciate all the support from my colleague Umayangani 
Wanninayake, Yang Qu, and John Romal, with whom I spent most of time in the research 
lab. The encouragement and happiness from them get me through all the difficulties in 
my Ph.D. study.   
 I would thank the Department of Chemistry at Iowa State University for providing 
financial support during my graduate study. My graduate research would not have been 
 viii 
completed without the help of Drs. Kamel Harrata, Shu Xu, and Sarah Cady from the 
chemical instrumentation facility.  
 I would like to thank all my friends for being around. I am very much thankful to 
Emma Kwolek, without whom I could not finish my dissertation in such a short time, as 
well as her family. I would also like to thank Katherine-Jo Galayda for helping me start 
my life in Ames. I owe special thanks to my wonderful friends in Chicago: Yan Li, 
Yingshuang Lv, Qiang Ma, Hongyi Mei, Wanlin Sun, Peng Wang, Yujuan Zheng and 
others who helped make my stay in Chicago a pleasant one. Their friendship and patience 
made my life in U.S. a colorful one. I would like to express my special gratitude to my 
best friends from my hometown: Xuankun He, Jing Yang, Lei Zhang, and Xinke Zhang. 
Their immense support and continuous encouragement always make me motivated to be 
successful. It is my great pleasure to have them in my life. 
Finally, I want to express my heartfelt thanks to my parents, Wei Dong and 
Gaixin Zhang and my extended family who have always been proud of me and fully 
supported my career decisions, even though I had to spend many years away from them. I 
owe my life to them for their constant love, encouragement, moral support and blessings, 
which makes me a better individual. 
 ix 
ABSTRACT 
 
 Natural products with interesting unique structures and special biological 
activities possess great potential in the development of novel pharmaceuticals. However, 
the evaluation of biological activity is always limited due to the low yield and difficulty 
of separation from plants and microorganisms. Synthetic organic chemistry provides an 
alternative tool to create such natural products from accessible materials. A huge mission 
for organic chemists is to develop novel strategies to produce natural products and their 
analogs in lab, as well as in quantitative scales. With this in mind, we have designed 
small molecule inhibitors towards Porcine reproductive and respiratory syndrome virus 
(PRRSV) and developed the synthetic routes to natural products psoracorylifols and 
furomollugin. In addition, a novel palladium nanoparticle catalyst was evaluated with the 
Suzuki-Miyaura reaction of aryl chloride.  
 Chapter one describes the design and synthesis of small molecule inhibitors of 
PRRSV. Natural 1-(E)- Atractylodinol was successfully produced in a seven-step direct 
route. More analogs with antiviral activity were synthesized based on this natural 
product. The goal to design a cost effective antiviral drug towards PRRSV was achieved.  
 The design of an approach to the unique 6,8-dioxabicyclo[3.2.1]octane skeleton in 
psoracorylifols B and C is discussed in chapter two. This special core structure was 
constructed via ketal formation in five steps. 
 The novel direct synthetic route to furomollugin is introduced in chapter 3. 
Furomollugin was synthesized by utilizing the Hauser-Kraus annulation as a key step.  
 x 
 The last chapter focuses on the evaluation and application of a novel palladium 
catalyst developed by Datye and co-workers. The utility of Datye catalyst was 
demonstrated in the Suzuki-Miyaura reaction of aryl chlorides and boronic acids. This 
catalyst showed great catalytic activity when aryl chlorides and aryl bromides were used 
for the Suzuki coupling in water media.
1 
CHAPTER 1. 
SMALL MOLECULE INHIBITORS TOWARDS PRRSV 
 
1.1. Introduction 
 
 Porcine reproductive and respiratory syndrome (PRRS) is caused by Porcine 
reproductive and respiratory syndrome virus (PRRSV). Porcine reproductive and 
respiratory syndrome (PRRS), also named blue ear disease, is a widespread disease 
affecting domestic pigs. The clinical symptoms of PRRS are complicated but can be 
characterized by severe reproductive losses including abortions, mummified fetuses, 
weak born and stillborn young, post-weaning pneumonia, increased mortality, and 
growth retardation of young pigs. PRRSV, a small enveloped RNS virus, belongs to the 
Arteriviridae family which includes lactate dehydrogenase-elevating virus (LDV) of 
mice, equine arteritis virus (EAV), and simian hemorrhagic fever virus (SHFV) also.1  
PRRS was first recognized in the United States in 1987, and the causative virus 
(PRRSV) was identified in Netherlands in 1991.2 Currently, the PRRSV isolates are 
divided into two distinct strains: North American strain, VR-2332, and the European 
strain, the Lelystad virus (LV).3, 4 Besides Europe and North America, it was also 
identified in China in 1995 and is present in Japan, Vietnam, the Philippines, Malaysia, 
and Korea among other agricultural countries in Asia. A few countries (Australia, New 
Zealand, several European countries, parts of Africa and India) did not find any evidence 
of this disease.5 
2 
After almost three decades, PRRS is still considered one of the most economically 
significant diseases in the global swine industry.6 In 2005, the annual costs of PRRS for 
the American swine industry were approximately 560 million dollars, and recently, the 
estimated costs have increased to about 664 million dollars per year in the United States, 
with an additional 360 million dollars in annual veterinary costs. 7, 8 Additionally, in June 
2006, an outbreak of a clinical syndrome called ‘‘high fever’’ emerged in pig farms and 
spread throughout more than 11 provinces in China, affecting over two million pigs 
within a few months, with high mortality rates, with PRRSV subsequently identified as 
the etiological agent.9 
Control of PRRS virus has proven to be a challenge for swine practitioners 
throughout the world due to the complexity of PRRS disease. To control PRRS, current 
management strategies focus on the biosecurity and vaccination to prevent spreading of 
PRRSV. The Biosecurity protocols are targeted at reducing transmission risks and 
typically fall into one of three categories: Hygiene/Sanitation, Separation and 
Exclusion.10 However, the biosecurity protocols can only be effective to the herds 
without disease, it is hard to eliminate the PRRS virus for the contaminated animals. 
Moreover, the biosecurity requires more personnel input and monetary investments to 
create a clean, virus free environment for uninfected pigs to stop infection. 
 Farmers combine biosecurity and vaccination to prevent the further economic loss 
caused by PRRS virus to increase the effectiveness of PRRS control. Vaccination is an 
effective tool to control PRRS if used correctly. The purpose of vaccination is to produce 
an immune response that will protect against clinical disease, but it does not prevent 
infection. Since PRRSV strains differ in virulence in infected pigs, it is important to 
3 
develop specific vaccination programs at the right time and place, based on individual 
farm diagnostic data, rather than promote standardized protocols. To control PRRS, 
modified live virus (MLV) vaccines appear to be more effective than killed preparations. 
Comparing with killed vaccines, MLV vaccines can give a strong, long-lasting immune 
response in fewer doses, have less chance to cause allergic reactions and behave more 
like the disease-causing virus. However, modified live vaccines should not be used in 
PRRS virus-negative herds, pregnant females, or breeding age boars. 
 Although vaccines are used to treat PRRSV nowadays, there are still some 
significant drawbacks for the use of vaccines. PRRSV is genetically heterogeneous. 
Extensive sequence variation was found between the European and the U.S. isolates.11 
Biological and antigenic variations among PRRSV have been well reported too.12 
Moreover, Pathogenesis and pathogenic variation have been well documented although 
the mechanism of PRRSV pathogenesis is poorly understand. All these variations of 
PRRSV and immune evasion would reduce the effectiveness of vaccines and contribute 
to PRRSV persistence within an animal or herd. The new approaches in vaccine design 
may help in the long term to control and eliminate PRRSV. However, there is a need for 
alternate strategies and tools to reduce the economic burden of PRRS in the short term.  
 Our alternative strategy to control PRRS is the development and use of potent 
antiviral drugs. Vaccines may provide protection against a virus after days. Unlike 
vaccines, antiviral drugs can provide almost immediate treatment for animals, which 
would be beneficial in the event of a new outbreak or emergence of new virus variants. 
The antiviral drugs can be added to food to feed animals, which makes it possible to treat 
large numbers of animals at one time. The vaccine treatment can only be supplied to a 
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small amount of pigs due to the single injection of vaccines. The antiviral drugs can also 
be used in periods of increased susceptibility, such as post-weaning and transport. The 
final goal of our project is to develop potent and cost-effective small molecule inhibitors 
of PRRSV based on the natural products. 
 
1.2.  Results and Discussion  
 
 This is a collaboration project between Kraus lab and Carpenter lab in the 
Department of Animal Science at Iowa State University. We are responsible for all the 
organic synthesis of the compounds in this project and Carpenter lab conducts the 
biological tests of synthetic compounds. Ethoxysanguinarine and atracylodinol (Figure 1) 
were reported useful as anti-PRRSV drugs by Li group in 2013,13 with IC50 values of 7.9 
and 39.4 µmol/L, respectively. We chose natural product compound 1 atractylodinol as 
our target molecule for synthesis. 
 
O
OH O
O
N
O
O
O
1
1-(E)-Atractylodinol Ethoxysanguinarine  
Figure 1. Structures of 1-(E)-Atractylodinol and Ethoxysanguinarin. 
 
 Natural 1-(E)- Atractylodinol was isolated from rhizomes of Atractylodes lancea. 
A. lancea is widely used in the traditional Chinese and Japanese medicines against 
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rheumatic diseases, digestive disorders, night blindness, and influenza.14 The aqueous 
extract of A. lancea also helps the delay in gastric emptying15 while the n-hexane extract 
of the rhizome exhibits good inhibitory activities in both 5-lipooxygenase (5-LOX) and 
cyclooxygenase-1 (COX-1) enzymatic in vitro assays.16  
 The reported isolation procedure gives 9.6 mg with about 70% of 1-(E)-
atracylodiol from 570 g of dried and powered A. lancea rhizomes.14 The low isolation 
yield and high cost cannot supply enough material for future biological activity tests in 
animals. Also to make the industrial quantitative production of the compound 1 is 
feasible, we decided to design a route to synthesize compound 1 in gram scale in the lab. 
The retrosynthetic route is shown in Scheme 1.  
 
O
OH O
2
+ OH
Br
3
OHHO
5
O O
H
4
1
 
Scheme 1. Retrosynthetic route of 1-(E)-atractylodinol. 
 
 In our synthetic plan, coumpond 1 could be achieved by coupling reaction of furyl 
enyne 2 and bromo alcohol 3. Furyl enyne 2 could be converted by well known Corey-
Fuchs reaction from commercially available material 3-(2-furyl)acrolein 4. From diol 5, 
compound 3 is accessible through several steps including protection of one hydroxyl 
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group with TBSCl, PCC oxidation of the remaining alcohol followed by dibromonation, 
and deprotection of TBS ether to give free hydroxy group.  
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O Br
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O
77% 86%
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n-BuLi, TBSCl
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96%
OTBSHO
O
H OTBS
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CH2Cl2
Molecular Sieve
75%
CBr4, PPh3
CH2Cl2, 0°C
Br
Br
OH
Br
96%
TBAF
THF, 45°C
66%
OTBS
CuCl, NH2OH HCl
EtNH2, MeOH
-78°C to rt
O
OH
25%
4 6 2
5 7 8
93
2
1
1-(E)-Atractylodinol  
Scheme 2. Total synthesis of 1-(E)-atractylodinol. 
 
 We started the synthesis from 3-(2-furyl)acrolein 4, as shown in Scheme 2. We 
chose to utilize Corey-Fuchs reaction to obtain the terminal alkyne from the aldehyde in 
two steps. Treatment of 4 with carbon tetrabromide and triphenylphosphine gave us 
dibromo compound 6, which was converted to furyl enyne 2.17 The two-step conversion 
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helped us to obtain intermediate 2 in a reasonable yield. The intermediate 2 played an 
important role in the whole project.  
 After successfully making enyne 2, we focused our attention toward the other part 
of the target molecule. Starting from cis-2-butene-1,4-diol 5, protection one hydoxyl 
group with with 1 equivalent of  tert-butyldimethylsilyl chloride at 0 °C gave TBS ether 
7.18 The terminal allylic alcohol was converted to  ,-unsuturated aldehyde 8 with 
oxidant pyridinium chlorochromate at room temperature in 75% yield. The condition of  
converting aldehyde 8 to dibromo TBS ether compound 9 was the same as the first step 
of Corey-Fuchs reaction, which was CBr4 and PPh3 at 0 °C. Treatment of compound 9 
with TBAF in THF at 45 °C resulted in deprotection of the TBS group with F-, as well as 
the elimiation of bromide with F- working as the base to make bromo enyne alcohol 3 in 
66% yield.19 
 After we had two coupling components in hand, we focused on finding the most 
suitable coupling condition. By utilizing a copper(I) catalyst with the apperence of ethyl 
amine and hydroxyamine hydrochloride in methanol, the Cadiot–Chodkiewicz coupling 
reaction of compounds 2 and 3 give us the desired natrual product 1 in 25% yield.19 
Although the yield was low for the final step, it was the only effective condition we 
found for this two- component coupling. To the best of our knowledge, no total synthesis 
route of 1-(E)-atractylodinol had been reported in literatures. Our synthetic route contains 
seven steps from two commercial available stating materials 3-(2-furyl)acrolein 4 and 
cis-2-butene-1,4-diol 5, the total yield is 11%.  
 The in vitro test conducted by Alyssa Evans from the Carpenter group showed the 
percentage virus netralization (PVN) of compound 1 was 100%, which means that our  
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synthetic compound 1 is effective towards PRRSV as it was reported. However, the 
difficuty of operation and low yield of the coupling reaction at the final step made the 
synthetic route impractical for large scale production. To achieve our project goal, there 
were two options to choose. One was to develop a better synthetic route for desired 
natrual product 1. The other one was to make natrual product analogs which have the 
same anti-PPRSV property as compound 1. We decided to continue the project following 
two directions simultaneously.   
 
CuCl, NH2OH HCl
EtNH2, MeOH
-78°C to rt
O
2
10
CuI
THF
60%
O + H O
OEt
11 12
I
OH
MnO2
14
CHCl3
Reflux
44%
O
O
OEt
13
O
N
I
10
Ph3P
O
O
14
 
Scheme 3. Original synthetic route of 13. 
 
 To improve the synthetic route for natrual product 1, as well as to make analog 13, 
we designed a new route as shown in Scheme 3. From the prepared enyne 4, the iodo 
enyne compound 11 was obtained with copper(I) catalyst and known morpholoine 
hydroiodide salt in 60% yield.20, 21 Acetylene 13 was prepared from propargyl alcohol. 
Oxidation with manganese dioxide followed with Wittig reaction with 
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(carbethoxymethylene)-triphenylphosphorane 14 converted propargyl alcohol to 
compound 13 in one pot, the E isomer was isolated in 30% yield after flash column 
chromatography purification. Copper catalyzed Cadiot–Chodkiewicz coupling reaction 
was used to build C-C bond between iodoalkyne 11 and acetylene 12. Unfortunately, the 
reaction did not go through as expected, ester analog 13 was not harvested after reaction 
and only the starting materials were recycled after the workup. 
 
O + I O
OEt
O
O
OEt
132
H O
OEt12
15
O
N
I
10
CuCl, NH2OH HCl
EtNH2, MeOH
-78°C to rt
35%
10
CuI
THF
99%
 
Scheme 4. Alternate synthetic route of 13. 
 
 Due to the faliture of the original plan at the final stage, a new route was required 
to continue our project. We did not want to start from the beginning, so enyne 2 was kept 
in the alternate plan. Instead of a coupling reaction between furyl iodoalkyne 11 and ester 
12, iodoalkyne 15 and enyne 2 were carried on to the coupling reaction. Compound was 
made from terminal alkyne 12 with morpholine hydroiodide salt 10, following the same 
procedure discribed before. The conversion yield was 99%, suprisingly high, compared to 
66% yield for compound 11. The same copper catalyzed coupling condition between 2 
and 15 gave us the target molecule ester 13 in 35% yield.  
10 
 It only took five steps to get compound 13 from commercially available materials. 
Compound 13 could be converted to natrual product 1 by one extra reduction step, which 
would give us a six-step synthetic route towards 1. The shorter plan was appealing; 
however, the low yield of the coupling and difficulty of operation would still be a 
problem to produce large amounts of the desired product for animal testing. Meanwhile, 
the antiviral activity of compound 13 was also tested, it neutralized 99.3% of the PRRSV 
in vitro, which was not effective enough towards PRRSV due to the quick reproduction 
of virus. The research of synthetic route improvement stoppted at this point. We changed 
our focus to the synthesis of analogs with antiviral activity. 
 Starting from the previously prepared enyne 2, homo-coupling reaction of termial 
alkyne 2 with iron(III) chloride and copper(I) bromide as co-catalyst gave us dimer 16 in 
36% yield in Scheme 5.22 To improve the yield of this reaction, we tried other possible 
conditions such as dimethyl formamide with copper(I) iodide as catalyst and 
tetrahydrofuran with nickel(II) chloride and copper(I) iodide as co-catalyst. However, all 
other conditions failed to deliver the dimer 16. So we dicided to adopt this method to 
make dimer 16 despite the yield being as low as 36% percent. The in vitro test showed 
that compound 16 neutralized 99.3% of PRRS virus, a significant improvement from 
ester 13, which was 95.6%. The result also showed that it was a valid plan to synthesize 
the anti-PRRSV natrual product analogs. 
 Although compound 16 neutrilized 95.6% of virus during in vitro test, it was still 
not an ideal antiviral drug because of the replication of virus. Afterwards, we put our 
focus mainly on the modification of compound 16 and development of new analogs. The 
plan of all the potential analogs are shown in schemes 5, 6, 7 and 8. 
11 
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Scheme 5. Synthesis of dimers 16, 17, 18 and 19. 
 
 Since dimer 16 showed good antiviral activity, our thought was to change the 
solubility of future analogs based on the structure of 16. The in vitro test was performed 
in serum, in which the major component was water solution, we hoped that the better 
solubility in polar sovents would increase the antiviral property of our compounds. To 
improve the solubitity of analogs in water, we focused on installing polar functional 
groups, such as carbonyl groups, hydroxy groups and amino groups, on to the dimer 16, a 
symmetric conjugated molecule. 
12 
 In the beginning, our attention was foucused on installing an aldehyde on the 
furan ring. The well known Vilsmeier–Haack reaction was used for the transformation 
from dimer 16 to aldehyde 17 as seen in Scheme 5. The reaction of the dimethyl 
formamide with phosphorus oxychloride produces an electrophilic iminium cation, then 
the subsequent electrophilic aromatic substitution on dimer 16 produces an iminium ion 
intermediate, which is hydrolyzed to give the desired furyl aldehyde in 33% yield.23, 24 To 
make the molecule more polar, the reduction reaction of aldehyde with NaBH4 was 
applied to convert 17 to alcohol 18 in THF and methanol in 98% yield.25 The in vitro test 
of aldehyde 17 and alcohol 18 showed that both compounds neutralized PRRSV 
effectively, the PVN is 96.6% and 98.6%, respectively. Although 17 and 18 would be 
useful against PRRSV potentially, the low yield of coupling step and formylation step 
limited the large scale production and application of these two drugs, besides the non-
100% neutralization activity towards PRRSV.  
 Giving up the plan of installing aldehyde and hydroxyl groups was frustrating, but 
a novel plan attracted our attention. As shown in Scheme 5, instead of putting an 
aldehyde group, we attempted to add dimethyl amino group on the structure. Utiliziing 
bis(dimethylamino)methane in acetic acid gave us aminomethylation product 19 in 60% 
yield,26 which neutralized 100% of virus in in vitro test as the natural product 1. The 
synthetic route we developed for analog 19 contains only four steps from commerially 
available material 3-(2-furyl)acrolein 4. Even though the yield for coupling step is only 
36%, the simple operation with mild unpreotected condition makes large scale production 
possible. Moreover, we could easily convert compound 19 into hydrochloride salt or 
formic acid salt by treating with the corresponding acid. The salts would be hard to 
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decompose and much more stable to store at room temperature. The salt form also has 
better solubility compared to orgnic compound 19 when added into food as drug to feed 
animals. So far, we have successfully designed a scalable route to synthesize an effecive 
analog as anti-PRRSV drug, which makes animal tests possible.  
 
O
O
H O
OHMgBr
Et2O
-78°C to rt
70%
MsCl,Et3N
CH2Cl2
53%
O
O
O
23
FeCl3, CuBr
CH3ONa
52%
2120 22
 
Scheme 6. Synthesis of 23. 
 
 With the success of antiviral drug 19, we continued to design more analogs. 
Another idea was to put two formyl groups on the molecule, the attempt is shown in 
Scheme 6. Firstly, we tried to get dimer 23 from 5-methyl furfural 20. Addition of freshly 
made propargylmagnesium bromide at -78 °C converted 20 into seconary alcohol 21 in 
70% yield. Protection of alcohol with MsCl, followed by elimiation with triethylamine 
yielded enyne 22 in 53% yield as the mixture of cis and trans isomers. The previously 
used coupling condition was applied again to produce dimer 23 in 52% yield. The 
coupling yield was higher than previous applications, maybe due to the electron donating 
effect of the attached methyl groups on furan rings. Unfortunately, utilizing SeO2 to 
14 
convert the terminal methyl groups into aldehyde groups falied. We could not make the 
dialdehyde compound as expected. However, the PVN value of compound 23 is 99%, 
which makes it as a good potential canditate for effective antiviral inhibitors. 
 
O O
O
RR
A B  
Scheme 7. Ring structure modification. 
 
 For further investigation, we intended to check whether the structrual stabilty of 
molecules would increase the antiviral property or not. As seen in Scheme 7, there are 
two double bonds in the furan ring and one double bond outside the ring structure, 
structure A on the left. The furan ring is not stable compared with a benzene ring, so we 
decided to put three double bonds together in one benzene ring to increase the structural 
stability. Moreover, the oxygen atom in furan ring was also kept in the structure B as the 
ether oxygen in the 5 member ring. Basically, we converted the furan ring structure A to 
a more stable benzene ring structure B keeping the same amount of double bonds and the 
oxygen atom. The synthetic route of target molecules ester 26 and dimer 27 are shown in 
Scheme 8. Both molecules started from the commercially available material piperonal. 
Corey-Fuchs reaction was used again to convert piperonal to termianl alkyne 25 in two 
steps, 70% yield. For 26, the same conditon towards ester 13 was applied to give desired 
product. The iron/copper catalyzed terminal alkyne coupling condition was used to yield 
dimer 27 in 25% yield. The follwing in vitro test result showed that PVN value of 
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compound 26 and 27 were 56% and 11%, respectively, which indicated that neither of 
these two compounds would be effective to eliminate PRRSV. Moreover, the low PVN 
values also revealed that the stable benzene ring would not increase the effectiveness of 
analogs and the furan rings were one of the most crucial components for the antiviral 
propertity of our designed small molecule inhibitors.  
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Scheme 8. Synthesis of 26 and 27. 
 
 Among all the privious synthesized molecules, we also found out that small 
simple molecules 2 and 12 showed anti-PRRSV activity. The PVN value of compound 2 
was 93.4% and 95.6% for compound 13. So we changed our focus on same small simple 
molecules which could be synthesized in less than four steps, and hoped that we could 
find a much more cost-efficient molecule inhibitor for PRRSV. The compounds we made 
16 
are ester 28, 29 and 30, beisdes secondary alcohol 21 which was an intermediate for 
compond 23, as seen in Scheme 9. 
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Scheme 9. Other small molesules for biology test. 
 
 The synthetic methods towards compound 29 and 30 are exhibted in Scheme 10. 
The Pd and Cu catalyzed Sonogashira coupling reaction was performed between terminal 
alkyne 2 and aryl bromide 31 to build a carbon-carbon bond to yield ester 29 in 31% 
yield. For compound 30, we started from furfural 32, followed by the treatment of CBr4 
and PPh3. Then the dibromo compound 33 was converted to bromo compound 34, which 
was a mixture of cis and trans isomers, with dimethyl phosphite (MeO)2POH and triethyl 
amine (Et3N) in DMF.27 However, unlike compounds 2 and 12, the new synthesized 
products 21, 29 and 30 all had poor antiviral activity with PVN value below 65%. In 
addition, the most interesting result was that the PVN value of compound 28 was -24%, 
the only negative value among all the compounds. It means that compound 28 stimulated 
the replication of PRRSV, instead of killing the virus. At this point, none of our attempts 
to develop a more cost-effective antiviral drug compared to compound 19 was achieved. 
17 
For future animal test on mice and pigs, compound 19 was still the best designed analog 
for mass production. 
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Scheme 10. Synthesis of 29 and 30.  
 
1.3. Conclusions 
 
 Natural 1-(E)-Atractylodinol 1 was successfully synthesized in seven steps and all 
the characterization data values (NMR and MS) of final product were identical to the 
literature values. One more efficient six-step synthetic route through ethyl ester analog 13 
of compound 1 was also proposed. Even though the final reduction step was not carried 
out, there is evidence to support the feasibility of the reduction step. To the best of our 
knowledge, neither of these two efficient synthetic routes had been reported before.  
18 
Moreover, a series of analogs were synthesized based on the natural product 1. 
We synthesized more than 15 molecules which were tested in vitro against PRRSV. The 
selective data of PVN is shown in Table 1. Among all the synthesized analogs, nine 
molecules showed more than 90% PVN value. Moreover, 10 µg of selected effective 
compounds could inactivate 103 to 105 infectious units of PRRSV and the EC50 values of 
effective compounds were 1-5 µg, respectively.  
Compound 19 is the most cost efficent product, only four steps from comercially 
available starting material 4 in high yied. The development of compound 19 make the 
animal test feasible in the near future. We will focus on the large production of antiviral 
drug 19, as well as the characterization method development for drug concentration level 
in serum.  
In summary, we have sucessfully achieved our goal in development of the samll 
molecule inhibitors towards PRRSV. More tests including the animal test would be 
carried out in the future.  
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Table 1. Percent virus neutralization with 10 µg compound/200 FFU Virus 
Number Stucture PVN (%) Number Stucture 
PVN 
(%) Number Stucture 
PVN 
(%) 
1 O
OH
 
100 2 O  93.4 12 H
OEt
O
 
95.6 
13 
O
OEt
O
 
99.3 16 
O
O
 
95.6 17 
O
O
O
H
 
96.6 
18 
O
O
OH
 
98.6 19 O
O
N
N  
100 21 O
OH
 
42 
23 
O
O
 
99.0 26 
O
O
OEt
O
 
56 27 
O
O
O
O
 
11 
28 O
O
OEt
 
-24 29 
O
O
OEt
 
65.7 30 
O
O
OMe
O
 
53 
19 
20 
1.4.  Experimental 
 
General Procedures
All starting materials were purchased from Sigma-Aldrich; THF was freshly 
distilled with LAH, other solvents were purchased from Fisher Scientific and used 
without further purification. All reactions were carried out in flame-dried glassware under 
argon with dry solvents under anhydrous conditions, unless specified. All yields refer to 
chromato-graphically isolated products. Reactions were monitored by thin- layer 
chromatography (TLC) carried out on 0.20 mm silica gel plates using UV light as a 
visualizing agent and potassium permanganate with heat as developing agents. Silica gel 
60Å, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 
13C NMR spectra were acquired on a Varian VXR-300 or Bruker DRX-500 spectrometer. 
1H and 13C chemical shifts (δ) are given in ppm relative to the residual protonated solvent 
peak (CDCl3: δH = 7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC =49.0 ppm; 
(CD3)2SO: δH = 2.50 ppm, δC = 39.52 ppm; (CD3)2CO: δH = 2.05 ppm, δC = 29.84 ppm) 
as an internal reference. Low resolution mass spectra (LRMS) were recorded on an 
Agilent 6540 QTOF (quadrupole time of flight) mass spectrometer using ESI 
(electrospray ionization) or APCI (atmospheric-pressure chemical ionization), or EI 
(electron ionization) on an Agilent 6890 GC/MS.  
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Selected Experimental, Physical, and Spectral Data  
O Br
Br  
(E)-2-(4,4-Dibromobuta-1,3-dien-1-yl)furan (6) : To a solution of CBr4 (2.6532 g, 8 
mmol) in CH2Cl2 (50 mL) at 0 °C, PPh3 (4.1966 g, 16 mmol) was added in portions over 
3 minutes. The color of solution changed to dark brown. After adding, the mixture was 
stirred for 10 minutes under argon gas protection. Acrolein 4 (0.4885 g, 4 mmol) was 
added to the resulting solution over 5 minutes portionwise. After another 30 minutes 
stirring at 0 °C, TLC was checked to make sure the reaction was done. Evaporation of 
CH2Cl2, followed by a quick flash column chromatography (silica gel, EtOAc:hexanes 
1:1) to remove most of salt gave a pale grey crude solid product. The purification of 
crude product by flash column chromatography (silica gel, EtOAc:hexanes 1:4) affored 6 
as a light yellow solid in 77% yield; 1H NMR (300 MHz, CDCl3) δ = 7.47–7.40 (m, 1H), 
7.02 (dd, J = 10.4, 0.5 Hz, 1H), 6.68 (dd, J = 15.5, 10.4 Hz, 1H), 6.54–6.36 (m, 3H). 
 
O
 
(E)-2-(But-1-en-3-yn-1-yl)furan (2): To a solution of dibromo compound 6 (0.5601 g, 
2.02 mmol) in 15 mL THF, n-BuLi (2.5 M in Hexane solution, 1.62 mL, 4.03 mmol) was 
added dropwise over 10 minutes at -78 °C under argon protection. The resulting mixture 
stirred at -78 °C for 1 h, the the temperature was increased to room temparature. After 1 h 
stirring at room temperature, saturated NH4Cl aqueous solution was added slowly to 
quench the reaction. The reaction mixture was extracted with diethyl ether (3 x 30 mL). 
The organic layers were collected, dried with anhydrous MgSO4, filtered and 
22 
concentrated in vacuo. The residue was purified by flash column chromatography (silica 
gel, pentane) to affored 2 as colorless oil in 86% yield; 1H NMR (300 MHz, CDCl3) δ = 
7.38 (d, J = 1.8 Hz, 1H), 6.78 (d, J = 16.1 Hz, 1H), 6.45 – 6.31 (m, 2H), 6.03 (d, J = 18.4 
Hz, 1H), 3.09 (d, J = 2.4 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ = 151.98, 143.43, 
130.34, 112.07, 110.68, 105.25, 83.04, 80.26. 
 
OTBSHO  
(Z)-4-((Tert-butyldimethylsilyl)oxy)but-2-en-1-ol (7): The diol 5 (0.4404 g, 5 mmol) 
was dissolved in anhydrous THF (20 mL), followed by addition of n-BuLi (2.5 M in 
Hexane solution, 2 mL, 5 mmol) at 0 °C over 5 minutes. After 1 h stirring at 0 °C, 5 mL 
THF solution of TBSCl (0.7536 g, 5 mmol) was added dropwise over 3 minutes. The 
resulting mixture was allowed to stir at room temperature for overnight. The reaction ws 
quenched by adding saturated NH4Cl aqueous solution, followed by extraction with 
diethyl ether (2 x 20 mL). The organic layers was combined, dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to give crude pruduct 7 in 96% yield. The 
crude product was used for next step without future purification; 1H NMR (300 MHz, 
CDCl3) δ = 5.78 – 5.61 (m, 2H), 4.31–4.16 (m, 4H), 0.91 (d, J = 1.4 Hz, 9H), 0.09 (d, J = 
2.8 Hz, 3H). 
 
O
H OTBS  
(E)-4-((Tert-butyldimethylsilyl)oxy)but-2-enal (8): Alcohol 7 (0.8201 g, 4.08 mmol) 
was added to a flame-dried flask with CH2Cl2 (15 mL)  and molecular sieve (1 g). PCC 
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(0.9062 g, 4.21 mmol) was added in one portion at 0 °C, the solution color changed to 
orange. After overnight stirring at room temperature, the solvent was evaporated in vacuo, 
diluted with diethyl ether. The resulting suspension was filtered through a short silica gel 
column to remove solid. The residue was purified by flash column chromatography 
(silica gel, EtOAc:hexanes 1:19) to affored 8 in 75% yield; 1H NMR (300 MHz, CDCl3) 
δ = 9.60 (d, J = 8.1 Hz, 1H), 6.89 (dt, J = 15.4, 3.3 Hz, 1H), 6.48–6.33 (m, 1H), 4.45 (dd, 
J = 3.3, 2.2 Hz, 2H), 0.92 (s, 9H), 0.09 (d, J = 1.6 Hz, 3H). 
 
Br
Br
OTBS
 
(E)-Tert-butyl((5,5-dibromopenta-2,4-dien-1-yl)oxy)dimethylsilane (9): Compound 9 
was prepared by using previous described procedure for compound 6 in 96% yield; 1H 
NMR (300 MHz, CDCl3) δ = 6.96 (d, J = 10.3 Hz, 1H), 6.42–6.26 (m, 1H), 6.14–6.00 
(m, 1H), 4.00 (d, J = 7.8 Hz, 2H), 0.91 (s, 9H), 0.08 (d, J = 7.5 Hz, 3H). 
 
OH
Br
 
(E)-5-Bromopent-2-en-4-yn-1-ol (3): To a solution of the dibromoalkene obtained 
above 9 (0.3832 g, 1.08 mmol) in THF was added TBAF (1.0 M solution in THF, 0.4 
mL, 0.4 mmol) at room temperature, then the mixture was stirred at 45 °C for 18 h and 
diluted with Et2O. The mixture was washed with saturated aqueous NH4Cl, H2O, and 
brine and then dried over MgSO4. Concentration gave the mixture of the corresponding 
TBS- deprotected bromoacetylene 3; 1H NMR (300 MHz, CDCl3) δ = 6.38–6.23 (m, 1H), 
5.72 (dt, J = 15.9, 1.9 Hz, 1H), 4.20 (dd, J = 5.0, 1.9 Hz, 2H). 
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1-(E)-Atractylodinol (1): To a solution of EtNH2 (70% aqueous solution, 2.2 mL) in 
MeOH (3 mL) was added CuCl (13.0 mg, 131.4 µmol) at room temperature that resulted 
in the formation of a blue solution. To the resulting mixture was added NH2OH·HCl 
(54.8 mg, 0.788 mmol) at room temperature to discharge the blue color. The resulting 
colorless solution indicated the presence of Cu(I) salt. To the resulting mixture was added 
2 (108.6 mg, 0.9196 mmol) in MeOH (2 mL) at room temperature, and the mixture was 
stirred at the same temperature for 10 min that resulted in the formation of a yellow 
suspension. To the resulting mixture was added bromoacetylene 3 (42.3 mg, 0.2627 
mmol) in MeOH (2 mL) at −78 °C, and mixture was stirred at the same temperature for 
30 min. The mixture was allowed to warm to room temperature for 3 h. The mixture was 
diluted with Et2O, washed with H2O and brine, and then dried over MgSO4. 
Concentration and flash column chromatography (silica gel, EtOAc:hexanes 1:4) gave 
the corresponding product 1; 1H NMR (300 MHz, CDCl3) δ = 7.39 (s, 1H), 6.81 (d, J = 
16.0 Hz, 1H), 6.41 (dt, J = 11.1, 4.5 Hz, 3H), 6.11 (d, J = 15.9 Hz, 1H), 5.88 (d, J = 15.9 
Hz, 1H), 4.26 (d, J = 3.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ = 152.03, 145.44, 
143.85, 131.30, 112.36, 111.55, 109.28, 104.83, 81.34, 81.09, 77.10, 75.03, 63.00.  
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(E)-2-(4-Iodobut-1-en-3-yn-1-yl)furan (11): To 10 mL THF was added enyne 2 (0.1386 
g, 1.17 mmol), morpholine hydroiodide salt (0.4787 g, 1.41 mmol) and CuI (0.0112 g, 
0.06 mmol) at room temperature. The reaction was monitored with TLC until no starting 
material left. Saturated aqueous NH4Cl solution was added to quench reaction, followed 
by the extraction with diethyl ether (3 x 15 mL). The combined organic layer was washed 
with saturated aqueous Na2S2O3, dried over anhydrous MgSO4, filtered and concentrated 
in vacuo; 1H NMR (300 MHz, CDCl3) δ = 7.37 (d, J = 1.8 Hz, 1H), 6.72 (d, J = 16.0 Hz, 
1H), 6.45 – 6.31 (m, 2H), 6.17 (d, J = 16.0 Hz, 1H). 
 
H O
OEt  
Ethyl (E)-pent-2-en-4-ynoate (12): To a flask with MnO2 (4.3470 g, 50 mmol), 14 
(2.0902 g, 6 mmol) in chloroform was added propargyl alcohol (0.2803 g, 5 mmol). The 
resulting mixture was refluxed for 18 h, and monitored with TLC. After reaction was 
finished, the mixture was filtered through celite, washed with CH2Cl2 and concentrated in 
vacuo. Diluted with pentane, filtered after 30 minutes stirring gave crude product. Flash 
column chromatography (silica gel, EtOAc:hexanes 1: 99) purification gave 12 in 45% 
yield; 1H NMR (300 MHz, CDCl3) δ = 6.25 – 6.06 (m, 2H), 4.24 (q, J = 7.2 Hz, 2H), 
3.60 (dd, J = 2.5, 0.8 Hz, 1H), 1.31 (d, J = 14.3 Hz, 3H). 
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I O
OEt  
Ethyl (E)-5-iodopent-2-en-4-ynoate (15): The same procedure as compound 11 gave 15 
in 99% yield; 1H NMR (300 MHz, CDCl3) δ = 6.25 – 6.06 (m, 2H), 4.24 (q, J = 7.2 Hz, 
2H), 3.60 (dd, J = 2.5, 0.8 Hz, 1H), 1.31 (d, J = 14.3 Hz, 3H). 
 
O
O
OEt
 
Ester (13): Compound 13 was prepared by using previous described procedure for 
compound 1 in 35% yield; 1H NMR (300 MHz, CDCl3) δ 7.41 (s, 1H), 6.93–6.77 (m, 
2H), 6.44 (d, J = 1.7 Hz, 2H), 6.32 (dd, J = 15.8, 2.7 Hz, 1H), 6.13 (d, J = 16.0 Hz, 1H), 
4.22 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H). 
 
O
O
 
(1E,7E)-1,8-Di(furan-2-yl)octa-1,7-dien-3,5-diyne (16): Enyne 2 (0.1226 g, 1.038 
mmol), FeCl3 (16.8 mg, 0.1038mmol), CuBr (7.5 mg, 0.052 mmol) and CH3ONa (162 
mg, 3 mmol) were added to 5 mL of THF under ambient temperature in the open air. The 
reaction mixture was stirred under room temperature for 20 h. The progress of the 
reaction was monitored by TLC. After completion of the reaction, the solvent was 
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removed under reduced pressure and the crude product obtained was purified by column 
chromatography over silica gel to afford 16 in 36% yield; 1H NMR (300 MHz, CDCl3) δ 
= 7.40 (d, J = 1.8 Hz, 2H), 6.82 (d, J = 15.8 Hz, 2H), 6.47–6.35 (m, 4H), 6.15 (d, J = 15.8 
Hz, 2H). 13C NMR (126 MHz, CDCl3) δ = 151.92, 143.65, 130.93, 112.18, 111.32, 
104.80, 82.54, 77.31. 
 
O
O
HO
 
5-((1E,7E)-8-(Furan-2-yl)octa-1,7-dien-3,5-diyn-1-yl)furan-2-carbaldehyde (17): To 
a DMF (2 mL) solution of Dimer 16 was added POCl3 slowly at 0 °C. The resulting 
mixture was allowed to stir at 0 °C for 1 h, room temperature for 1 h, then 80 °C for 10 
minute. When the reaction cooled down, aqueous NaOAc solution was added, followed 
by the extraction with CH2Cl2 (3 x 15 mL). Organic layer was washed with water, brine, 
dried over anhydrous MgSO4. Concentration and flash column chromatography (silica 
gel, EtOAc:hexanes 4:1) gave compound 17 in 33% yield; 1H NMR (300 MHz, CDCl3) δ 
= 9.61 (s, 1H), 7.41 (s, 1H), 7.23 (d, J = 3.7 Hz, 1H), 6.84 (dd, J = 15.9, 3.1 Hz, 2H), 
6.59–6.50 (m, 2H), 6.50–6.39 (m, 2H), 6.15 (d, J = 15.9 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ = 177.37, 156.51, 152.41, 151.78, 143.89, 131.58, 129.33, 122.86, 112.63, 
112.28, 111.80, 111.35, 104.35, 84.34, 81.32, 80.44, 76.93. 
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(5-((1E,7E)-8-(Furan-2-yl)octa-1,7-dien-3,5-diyn-1-yl)furan-2-yl)methanol (18): To a 
flask with aldehyde 17 (10 mg, 0.038 mmol) and THF:Methnol (1:1) solution was added 
NaBH4 portionwise. After stirring at room temperature for 2 h, the solvent was 
evaporated under reduced pressure. The residue was extracted with H2O (5 mL) and 
EtOAc (3 x 10 mL). Organic layer was dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to give crude pruduct. 18 was obtained by flash column 
chromatography purification over silica gel (EtOAc:hexanes 1:4-1:2); 1H NMR (300 
MHz, CDCl3) δ 7.40 (s, 1H), 6.88 – 6.72 (m, 2H), 6.47 – 6.28 (m, 4H), 6.15 (d, J = 15.9 
Hz, 2H), 4.61 (s, 2H). 
 
O
O
N
N
 
1,1'-(((1E,7E)-Octa-1,7-dien-3,5-diyne-1,8-diyl)bis(furan-5,2-diyl))bis(N,N-
dimethylmethanamine) (19).: To a solution of 13 (0.1287 g, 0.549 mmol) in glacial 
AcOH (2 mL) cooled to below 10 °C as added portionwise, bis(dimethlyamino)methane 
(0.1684 g, 0.549 mmol), while the temperature was maintained at about 12 °C. The 
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solution was then allowed to rise to room temperature and left to stand overnight. The 
orange solution was poured onto crushed ice and stirred while K2CO3 (5 g) was added in 
portions, followed by extraction with CH2Cl2, (3 x 15 mL). Extracts were combined and 
back-extracted into 2% aqueous HCl (3 x 20 mL). Reneutralization to pH 10.5 with 
K2CO3, followed by extraction with CH2Cl2, drying MgSO4, and concentration gave 19 
in 60% yield; 1H NMR (500 MHz, CDCl3) δ 6.74 (d, J = 15.9 Hz, 2H), 6.30 (d, J = 3.3 
Hz, 2H), 6.22 (d, J = 3.3 Hz, 2H), 6.11 (d, J = 15.9 Hz, 2H), 3.44 (s, 4H), 2.25 (s, 12H). 
13C NMR (126 MHz, CDCl3) δ = 154.07, 151.61, 130.81, 112.02, 111.16, 104.39, 82.69, 
77.31, 55.92, 45.09. 
 
O
OH
 
1-(5-Methylfuran-2-yl)but-3-yn-1-ol (21): To a three-neck flask with 10 mL of 
anhydrous diethyl ether and Mg turning (0.0576 g, 2.4 mmol) was added propargyl 
bromide (0.2 mL, 2.4 mmol) dropwise. The reflux was kept by slow addition of propargyl 
bromide. After addition, the reaction was allowed to cool down to room temperature 
slowly in 2 h. Freshly prepared propargylmagnesium bromide was transfer to another 
flask with 5-methylfurfural (0.2 mL, 2 mmol) in diethyl ether solution (5 mL) by cannel 
at -78 °C. The reaction was quenched by adding saturated NH4Cl aqueous solution after 2 
h, followed by extraction with diethyl ether (3 x 20 mL). The organic layers was 
combined, dried over anhydrous MgSO4, filtered and concentrated in vacuo to give crude 
pruduct 21 in 70% yield, which was used without further purification; 1H NMR (300 
30 
MHz, CDCl3) δ = 6.21 (d, J = 3.1 Hz, 1H), 5.96–5.82 (m, 1H), 4.82 (t, J = 6.3 Hz, 1H), 
2.81–2.71 (m, 2H), 2.37–2.25 (m, 3H), 2.07 (t, J = 2.7 Hz, 1H). 
O
 
(E)-2-(But-1-en-3-yn-1-yl)-5-methylfuran (22): To a solution of alcohol 21 (0.1521g, 
1.0 mmol) and Et3N (0.42 mL, 3.0 mmol) in CH2Cl2 (10 mL) was added MsCl (0.10 mL, 
1.3 mmol) at 0 °C. The reaction was monitored by TLC after 2 h. Saturated NH4Cl 
aqueous solution was added once the reaction completion, followed by extraction with 
diethyl ether (3 x 20 mL). The organic layers was combined, dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to give crude pruduct 22 in 55% yield, which 
was mixture of cis and trans isomers; 1H NMR (300 MHz, CDCl3) δ = 7.00 (d, J = 3.3 Hz, 
0.37H), 6.71 (d, J = 16.0 Hz, 0.62H), 6.60 (d, J = 11.9 Hz, 0.38H), 6.24 (d, J = 3.2 Hz, 
0.60H), 6.09–5.71 (m, 1.64H), 5.40 (dd, J = 11.9, 2.6 Hz, 0.37H), 5.30 (s, 0.35H), 3.44 (s, 
0.34H), 3.06 (d, J = 2.5 Hz, 0.57H), 2.32 (d, J = 3.1 Hz, 3H) 
 
O
O
 
(1E,7E)-1,8-Bis(5-methylfuran-2-yl)octa-1,7-dien-3,5-diyne (23): The compound 23 
was obtained according previous coupling procedure for compound 16; 1H NMR (300 
MHz, CDCl3) δ = 6.98 (d, J = 3.4 Hz, 1H), 6.75 (dd, J = 15.8, 10.2 Hz, 1H), 6.64 (dd, J = 
11.8, 7.4 Hz, 1H), 6.28 (t, J = 4.0 Hz, 1H), 6.15–6.00 (m, 3H), 5.52 (dd, J = 11.8, 9.4 Hz, 
1H), 2.38–2.29 (m, 6H).  
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5-(2,2-Dibromovinyl)benzo[1,3]dioxole (24): The compound 24 was obtained according 
previous described procedure of compound 6; 1H NMR (300 MHz, CDCl3) δ = 7.37 (d, J 
= 0.7 Hz, 1H), 7.19 (d, J = 1.8 Hz, 1H), 7.00–6.90 (m, 1H), 6.80 (d, J = 8.1 Hz, 1H), 5.99 
(s, 2H).  
 
O
O
H
 
5-Ethynylbenzo[1,3]dioxole (25): The compound 25 was obtained according previous 
described procedure of compound 2; 1H NMR (300 MHz, CDCl3) δ = 7.07 – 6.98 (m, 
1H), 6.93 (d, J = 1.6 Hz, 1H), 6.75 (dd, J = 8.0, 0.4 Hz, 1H), 5.98 (s, 2H), 2.97 (s, 1H). 
 
O
O
O
OEt
 
Ethyl (E)-7-(benzo[d][1,3]dioxol-5-yl)hepta-2-en-4,6-diynoate (26): The compound 26 
was obtained according previous described procedure of compound 1; 1H NMR (300 
MHz, CDCl3) δ = 7.07 (dd, J = 8.2, 1.6 Hz, 1H), 6.93 (d, J = 1.6 Hz, 1H), 6.89–6.72 (m, 
2H), 6.33 (d, J = 15.8 Hz, 1H), 6.00 (s, 2H), 4.23 (q, J = 7.2 Hz, 2H), 1.30 (t, J = 7.1 Hz, 
3H). 
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1,4-Bis(benzo[d][1,3]dioxol-5-yl)buta-1,3-diyne (27): The compound 27 was obtained 
according previous described procedure of compound 16; 1H NMR (300 MHz, CDCl3) δ 
= 7.06 (dd, J = 8.1, 1.6 Hz, 2H), 6.94 (d, J = 1.6 Hz, 2H), 6.76 (d, J = 8.0 Hz, 2H), 5.99 
(s, 4H). 
 
O
O
OEt
 
Ethyl (E)-4-(4-(furan-2-yl)but-3-en-1-yn-1-yl)benzoate (29): To a mixture of enyne 2 
(0.0591 g, 0.5 mmol), ester 31 (0.0764 g, 0.33 mmol), PdCl2(PPh3)2 (12.0 mg, 16.5 µmol) 
and CuI (3.3 mg, 16.5 µmol) in toluene was added DBU (0.1 mL). The solution color 
changed from yellow to dark brown after addition. The resulting mixture was allowed to 
stir at room temperature, under argon, for 24 h, then filtered and concentrated in vacuo. 
29 was obtained by flash column chromatography purification over silica gel 
(EtOAc:hexanes 1:9); 1H NMR (300 MHz, CDCl3) δ 8.04–7.95 (m, 2H), 7.55–7.45 (m, 
2H), 7.41 (d, J = 1.8 Hz, 1H), 6.83 (d, J = 16.0 Hz, 1H), 6.48–6.35 (m, 2H), 6.28 (d, J = 
16.0 Hz, 1H), 4.38 (q, J = 7.1 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
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O Br
Br  
2-(2,2-Dibromovinyl)furan (33): The compound 33 was obtained according previous 
described procedure of compound 6; 1H NMR (300 MHz, CDCl3) δ 7.47 – 7.37 (m, 2H), 
6.95 (d, J = 3.5 Hz, 1H), 6.46 (dd, J = 3.5, 1.8 Hz, 1H). 
 
O Br
 
2-(2-Bromovinyl)furan (34): To a solution of dibromo 33 (1.8675 g, 7.4 mmol) in DMF 
was added (MeO)2POH (3.2634 g, 29.7 mmol) and Et3N (3.3757 g, 33.4 mmol). The 
resulting solution was heated to reflux for 20 h. After reaction completion, the mixture 
was quenched with a saturated aqueous solution of NH4Cl and extracted with ethyl 
acetate (3 x 10 mL). The organic extracts were dried over MgSO4, and concentrated in 
vacuo. The residue was purified by flash column chromatography giving compound 34. 
 
O
O
OMe
O
 
Methyl 5-(4-(furan-2-yl)but-3-en-1-yn-1-yl)furan-2-carboxylate (35): A solution of 
alkyne 35 (0.0364 g, 0.242mmol) in THF (2 mL) was added at room temperature, under 
argon, to a stirred mixture of 34 (0.0381 g, 0.221 mmol), PdCl2(PPh3)2 (4.3 mg, 6 µmol), 
CuI (2.3 mg, 12.1 µmol), and Et3N (50µL, 36.3 µmol ) in THF (2 mL). After reaction 
completion (1 h), the mixture was quenched with a saturated aqueous solution of NH4Cl 
34 
and extracted with ethyl acetate (3 x 10 mL). The organic extracts were washed with a 
saturated aqueous solution of NaCl, dried over MgSO4, and concentrated in vacuo. The 
residue was purified by flash column chromatography leading to compound 35 in 45% 
yield.: 
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CHAPTER 2. 
SYNTHETIC APPROACH TO THE PSORACORYLIFOLS* 
 
2.1. Introduction 
 
Psoracorylifols A–C (1–3 in Figure 1) were isolated from the seeds of Psoralea 
corylifolia L. (Fabaceae), a well-known traditional Chinese medicine, which has been 
applied to cure gynecological bleeding, vitiligo and psoriasis.1 In 2006, Yue and co-
workers identified and characterized these molecules.2 They reported that psoracorylifols 
A–C showed potent inhibitory activity against two strains of Helicobacter pylori (SS1 
and ATCC 43504) with MICs of 25.0, 12.5 and 12.4 µg/mL, respectively.2 Compounds 2 
and 3 were especially effective against H. pylori-ATCC 43504, a drug resistant strain. 
These compounds exhibited activities ten times stronger than metronidazole, which is a 
critical ingredient for combination therapies of H. pylori infections.3  
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Figure 1. Structures of psoracorylifols A (1), B (2), and C (3). 
                                                
* Adapted with permission from Kraus, G. A.; Dong, P., Nat. Prod. Commun. 2014, 9, 
309-310. Copyright © 2014 Natural Product Inc.  
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The 6,8-dioxabicyclo[3.2.1]octane skeleton is a common structural subunit which 
can be found in many biologically active natural products.4 The selected synthetic routes 
to build such bicyclic ketals are shown in Scheme 1. Periodic acid cleavage of the 
cyclohexane triol gives the bicyclic ketal through a dialdehyde intermediate, as shown in 
Scheme 1(a).5 The structure can also be derived from an epoxide in high yield, which 
Wasserman and co-workers discovered as part of a study on the rearrangement of 
carbonyl-epoxides, as shown in Scheme 1(b).6 Moreover, this unique bicyclic skeleton 
can be prepared from a diol and a ketone or a diol and an aldehyde, which is made by 
deprotection of  the carbonyl group or the hydroxyl groups in situ, as illustrated in 
Scheme 1(c).7 In Scheme 1(d), an interesting method is shown to build a similar unit. 
Grignard and organolithium reagents attack the ketone and the desired structure forms 
after cyclization.8 Cyclization of a pyranyl carbinol with lead tetraacetate via a radical 
mechanism has been reported to form the 6,8-dioxabicyclo[3.2.1]octane skeleton in low 
yields, as seen in Scheme 1(e).9  
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Scheme 1. Some synthetic routes to bicyclic ketals. 
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Recently, Hashimoto and coworkers reported a synthesis of the core skeleton for 
the psoracorylifols, as shown in Scheme 2.10They developed a novel catalytic asymmetric 
method to construct the exo-7-aryl-6,8-dioxabicyclo[3.2.1]octane framework of 
psoracorylifols B (2) and C (3). The exo- and enantioselective cycloadditions of a six-
membered carbonyl ylide derived from 1-diazo-6-methyl-2,5-heptanedione (4) with 
aromatic aldehydes under the catalysis of chiral dirhodium(II) catalyst, have been 
achieved with high levels of asymmetric induction (up to 87% ee) by the use of electron-
rich aromatic aldehydes. Although this method was able to generate the desired 
framework unit, it comes with some practical challenges. For example, the complete 
removal of transition-metal catalysts is important since the presence of metals could 
affect the bioactivity evaluation process. Furthermore, the preparation and strict 
operational conditions of the catalyst limit the industrial application.  
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Scheme 2. Core structure construction of psoracorylifols B and C.  
 
2.2. Results and Discussion 
 
Our goal was to develop a more direct and strategically different synthetic route 
to psoracorylifol analogs that could be readily extendable to single enantiomer synthesis. 
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In order to identify an efficient synthetic pathway, we initially explored the strategy, as 
shown in Scheme 3. We chose to use ketal formation as a key reaction to build such a 
skeleton. Compound 8 was chosen as the targeted model system based on the framework 
of psoracorylifols. The 6,8-dioxabicyclo[3.2.1]octane skeleton could be constructed by 
cyclization after epoxide ring opening in compound 9 or dihydroxylation of the double 
bond in compound 10. Both 9 and 10 would be converted from a keto aldehyde, which is 
prepared using the Michael addition of the enol silyl ether of isobutyraldehyde 12 with 
isopropyl vinyl ketone 13.  
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Scheme 3. Retrosynthesis of 8. 
 
Starting with isobutyraldehyde 12, addition of vinylmagnesium bromide 14 at -78 
°C gave the secondary allylic alcohol 15 in 75% yield, as seen in Scheme 4. A Jones 
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oxidation converted the secondary allylic alcohol 15 to a ,-unsuturated ketone 13 in 
60% yield at 0 °C.11 After the preparation of compound 13, enol silyl ether 16 was 
obtained from ketone 12 with the treatment of TMSCl and triethylamine at 110 °C in 
74% yield.7 With both compounds 16 and 13 in hand, we attempted to connect the two 
molecules by utilizing a Micheal addition. Keto aldehyde 11 was formed in two methods: 
one condition was with the Lewis acids aluminum oxide and boron trifluoride etherate at 
0 °C, the second condition was with titanium (IV) chloride at -78 °C.12, 13 Both conditions 
yielded keto aldehyde 11 based on the analysis of their respective NMR spectra , 
however neither of  them gave us a pure product 11 due to the difficulty of separation. At 
this point, we used this material 11 for the next step without futhur purification. 
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Scheme 4. Synthesis of keto aldehyde 11. 
 
Our strategy for the next step was to prepare epoxide 9 or alkene 10, as shown in 
Scheme 5. For epoxide 9, commercially available sulfonium salt 17 was used according 
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to the previously reported work done by our lab.14 Potassium tert-butoxide was used as a 
strong base to form the anion at the benzylic position of sulfonium salt 17 by 
deprotonation. This molecule was then used to attack the aldehyde in compound 11 to 
form the epoxide by kicking off the dimethyl sulfide. However, epoxide 9 was not 
formed as we proposed. Furthermore, treatment with (nitromethyl)benzene 18 was not 
successful in producing the desired epoxide. Attemps to produce alkene 10 with the 
Wittig reagent triphenylphosphine benzyl bromide 19 did not work either. Analysis of the 
NMR spectra of the unpurified reaction suggested that intermolecular aldol-derived side 
reactions had intervened. Unfortunatelly, our original proposed synthetic route was 
abandoned at this stage due to the failure of synthesizing epoxide 9 and alkene 10.  
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Scheme 5. Synthesis of 9 and 10. 
 
 After the failure of our first synthetic plan, we came up with an alternative route, 
shown in Scheme 6. The desired product 8 would be converted from acid 20 after 
nucleophilic addition with isopropylmagnesium chloride and dihydroxylation with 
osmium tetroxide. Acid 20 could be synthesized from a Wittig reaction between 
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triphenyl phosphonium salt 19 and nitrile aldehyde 21 followed by the hydrolysis of a 
nitrile group. Isobutyraldehyde 12 and acrylonitrile would be used to make nitrile 
aldehyde 21. Compared with the first plan, this route installed the isopropyl group on the 
molecule at the end of synthesis with the addition of isopropylmagneisium chloride, 
instead of making the isopropyl vinyl ketone at the beginning of synthesis. Both plans 
started from same starting material isobutyraldehyde 12. 
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Scheme 6. Alternative route. 
 
 To test our proposed plan, we began with the synthesis of nitrile aldehyde 21 from 
aldehyde 12 and acrylonitrile 22, as seen in Scheme 7. According to the method of 
Bruson15, acrylonitrile was slowly added into the solution of aldehyde 12 and potassium 
hydroxide. Since is an exothermic reaction, the temperature of reaction must be 
monitored and kept below 55 °C during and after addition. The nitrile aldehyde 21 was 
purified with the Kugelrohr short path distillation to give a colorless liquid. This 
compound had the advantage that it could be made in 67% yield in multigram quantities. 
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Fortunately, the reaction of triphenyl phosphonium salt 19 and n-butyllithium with 
aldehyde 21 provided nitrile cis isomer 23a in 65% yield after silica gel chromatography, 
as shown in Scheme 6. (85% yield for 23a and 23b, 23a:23b=6:1). Hydrolysis of 23a 
with KOH in a co-solvent of ethanol and water provided carboxylic acid 20 in 85% 
yield.16  
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Scheme 7. Synthesis of compound 26. 
 
Although the resulting olefinic acid 20 could not be epoxidized with mCPBA, it 
did react with catalytic osmium tetraoxide and trimethylamine N-oxide dihydrate in 
acetone and water. Following this was a coupling reaction with DCC and DMAP to give 
lactone 24 in 52% yield for two steps, as shown in Scheme 7.17 Lactone 24 reacted 
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readily with isopropylmagnesium chloride at -78 °C to afford ketal 26 in 33% yield, after 
a workup with an aqueous ammonium chloride solution. We tried to utilize 
isopropylmagnesium chloride to convert the nitrile group to ketone 27 in one step, which 
should be a easy step according to the literature. However, all our attempts failed to form 
the desired ketone 27 with this method. After some experimentation, we found that acid 
20 reacted with thionyl chloride followed by an addition of isopropylmagnesium chloride 
at -78 °C in THF with the appearance of copper (I) iodide to form the ketone 27 in 94% 
yield.  The reaction of ketone 27 with catalytic osmium tetraoxide and trimethylamine N-
oxide dihydrate followed by treatment with PTSA afforded 26 in 53% yield. The second 
route to produce compound 26 through alkene 27 gave a higher overall yield compared to 
the route via lactone 24.  
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Scheme 8. Three-dimensional structure of 8 and 26. 
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 After compound 26 was obtained, we tried to confirm the structure by comparing 
the NMR spectrum data of 26 with data in the literature.2 In our compound 26, the 
coupling constant for the methines protons Ha and Hb was 4.6 Hz, which indicated that 
there was coupling between the two protons. However, according to the literature, the 
coupling constant for the adjacent methine protons Hc and Hd in compound 8 should be 
less than 1 Hz, since it had the same stereochemistry in the dioxabicyclo[3.2.1]octane 
skeleton as psoracorylifol B (2). Based on this data, we concluded that the stereo-
structure of compound 26 should be 26a in Scheme 8. Comparing structure 26a with 8a, 
the interacton between Ha and Hb in 26a caused the splitting of these two protons 
resulting in the coupling constant with a value of 4.6 Hz. The low coupling constant 
between Hc and Hd can be explained with the dihedral angle between Hc and Hd in 
structure 8a, which was close to 90°. 
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Scheme 9. Synthesis of analog 32. 
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Even though the stereochemistry of compound 26 was different with our target 
model molecule 8, the dioxabicyclo[3.2.1]octane core structure could be formed by this 
direct method. For further investigation, we hypothesized a new pathway, in which the 
stereochemistry of the core structure would be constructed with the trans olefinic acid 
instead of cis isomer 20. To check our hypothesis, as well as to synthesize a closer analog 
32, we reacted nitrile aldehyde 21 with 4-methoxybenzyl(triphenyl)phosphorene 28 to 
give trans and cis isomers, as shown in Scheme 9. All of the cis isomer in the crude 
mixture was converted to the trans isomer by radical rearrangement initialized with 
azobisisobutyronitrile and thiophenol in refluxing benzene.18 This two-step procedure 
produced the trans isomer as the major product of the Wittig reaction and increased the 
yield to 91%, compared to 12% for 23b in Scheme 6. Hydrolysis of the nitrile group 
converted it to a carboxylic acid with potassium hydroxide in aqueous ethanol at reflux in 
94% yield. Treatment of acid 30 with thionyl chloride at high temperature followed by 
the addition of isopropylmagnesium chloride with copper (I) iodide at -78 °C formed 
ketone 31 in 95% yield for 2 steps. Final product 32 was derieved from 31 in 61% yield 
with the same procedure used for 26, catalytic osmium tetraoxide and trimethylamine N-
oxide dihydrate followed by treatment with PTSA. The coupling constant for the adjacent 
methine protons in compound 32 was less than 1 Hz, which indicated that ketal 32 had 
the same structure as psoracorylifol B (2).  
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2.3. Conclusions  
  
 Yue and coworkers first isolated psoracorylifols, a well-known traditional 
Chinese medicine, in 2006 from the seeds of Psoralea corylifolia L.2 Since then 
psoracorylifols B (2) and C (3) attracted our attention due to their unique 6,8-
dioxabicyclo[3.2.1]octane skeleton and valuable biological activities. In our work, we 
utilized ketal formation as the key step to form this unique bicyclic structure. The 
synthetic route we developed to synthesize ketal 32 only contains five steps from 
isobutyraldehyde 12 in 40% yield. The bicyclic ketal structure was confirmed by 
comparing NMR spectrum data with literature. This route will enable the analysis of 
stereoisomeric analogs of 2 in order to better understand the mechanism of action of this 
novel family of natural products.  
 
2.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich; THF was freshly 
distilled with LAH, other solvents were purchased from Fisher Scientific and used 
without further purification. All reactions were carried out in flame-dried glassware under 
argon with dry solvents under anhydrous conditions, unless specified. All yields refer to 
chromato-graphically isolated products. Reactions were monitored by thin layer 
chromatography (TLC) carried out on 0.20 mm silica gel plates using UV light as a 
visualizing agent and potassium permanganate with heat as developing agents. Silica gel 
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60Å, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 
13C NMR spectra were acquired on a Varian VXR-300 spectrometer. 1H and 13C 
chemical shifts (δ) are given in ppm relative to the residual protonated solvent peak 
(CDCl3: δH = 7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC =49.0 ppm; 
(CD3)2SO: δH = 2.50 ppm, δC = 39.52 ppm; (CD3)2CO: δH = 2.05 ppm, δC = 29.84 ppm) 
as an internal reference. High resolution mass spectra (HRMS) were recorded on an 
Agilent 6540 QTOF (quadrupole time of flight) mass spectrometer using ESI 
(electrospray ionization) or APCI (atmospheric-pressure chemical ionization), or EI 
(electron ionization) on an Agilent 6890 GC/MS.  
 
Selected Experimental, Physical, and Spectral Data 
OH
 
4-Methylpent-1-en-3-ol (15): To a solution of isobutyraldehyde (0.365 mL, 4 mmol) in 
THF (5 mL) was added vinylmagnesium bromide ( 1M in THF solution, 4.8 mL, 4.8 
mmol) dropwise at 0 °C. After 30 minutes at 0 °C, the solution was allowed to warm to 
room temperature and sit for another 2 h. Saturated NH4Cl aqueous solution was added 
slowly to quench the reaction followed by extraction with diethyl ether (3 x 30 mL). The 
organic layers were collected, dried with anhydrous MgSO4, filtered and concentrated in 
vacuo. The residue was purified by flash column chromatography (silica gel, 
Et2O:pentane 1:9 ) to affored 15 as light yellow oil in 75% yield; 1H NMR (300 MHz, 
CDCl3) δ = 5.85 (ddd, J = 17.1, 10.4, 6.5 Hz, 1H), 5.29 (s, 1H), 5.27 – 5.08 (m, 2H), 3.90 
– 3.79 (m, 1H), 1.79 – 1.65 (m, 1H), 1.00 – 0.78 (m, 6H). 
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4-Methylpent-1-en-3-one (13): To a solution of secondary alcohol 15 (0.2313 g, 2.3 
mmol) in acetone (5 mL) at 0 °C was added a diluted Jones reagent ( 1 mL 8 N Jones 
reagent in 9 mL acetone) dropwise over 20 minutes until the orange color persisted. 2-
Isopropanol was added dropwise until the color turned to dark green. The resulting 
mixture was concentrated and extracted with diethyl ether (3 x 30 mL). The organic layer 
was washed with water, sodium bicarbonate solution and brine, dried with anhydrous 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash column 
chromatography (silica gel, Et2O:pentane 1:9 ) to affored 13 as light yellow oil in 60% 
yield; 1H NMR (300 MHz, CDCl3) δ = 6.52 – 6.36 (m, 1H), 6.26 (dd, J = 17.5, 1.7 Hz, 
1H), 5.77 (dd, J = 10.4, 1.6 Hz, 1H), 2.96 – 2.75 (m, 1H), 1.13 (d, J = 6.9 Hz, 6H). 
 
OTMS
 
Enol silyl ether (16): To a flame-dried flask with isobutyraldehyde (0.183 mL, 2 mmol) 
and triethylamine (0.418 mL, 3 mmol) in DMF (2 mL) was added TMSCl (0.381 mL, 2 
mmol). The mixture was heated at 110 °C for 3 h. After the reaction was cooled down, 
pentane (3x 20 mL) was added into flask. The clear pentane layer was collected, 
combined and concentrated in vacuo to give 16 in 74% yield; 1H NMR (300 MHz, CDCl3) 
δ = 6.00 (dd, J = 2.8, 1.4 Hz, 1H), 1.56 (d, J = 14.5 Hz, 6H), 0.16 (s, 9H). 
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2,2,6-Trimethyl-5-oxoheptanal (11): Method A: The mixture of enone 13 (0.1350 g, 
1.38 mmol), enol silyl ether 16 (0.1168g, 0.81 mmol), Al2O3 (0.5780 g) and ZnCl2 
(0.1560 g) was stirred at 0 °C for 30 minutes. After adding BF3 etherate (0.2142 g, 0.17 
mmol), the resulting mixture was stired at 0 °C for another 4 hours. Saturated NH4Cl 
aqueous solution was added slowly to quench the reaction followed by extraction with 
diethyl ether (3 x 30 mL). The organic layers were collected, dried with anhydrous 
MgSO4, filtered and concentrated in vacuo to give crude product 11.  
 
Method B: To a flame-dried flask with TiCl4 (1 M solution in CH2Cl2, 0.54 mL, 0.54 
mmol) was added enone 13 (0.053 g, 0.54 mmol) in CH2Cl2 at -78 °C. After stirring for 
10 minutes, enol silyl ether 16 (0.0792 g, 0.54 mmol) was added at -78 °C dropwise. The 
reaction mixture was allowed to stir at – 78 °C for another 5 minutes, then quenched with 
saturated sodium bicarbonate aquesous solution. Diethyl ether was added for extraction 
(3 x 20 ml). The extracte was dried with anhydrous MgSO4, filtered and concentrated in 
vacuo to give crude keto aldehyde 11.  
 
H
O N
 
4,4-Dimethyl-5-oxopentanenitrile (21): To a solution of isobutyraldehyde (4 g, 5.06 
mmol) and 50% aqueous KOH (0.2 g) was added acrylonitrile slowly at 0 °C. The 
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temperature was allowed to go back to room temperature after addition. After stirring at 
room temperature for 1 h and 55 °C for one hour, 4 M HCl aqueous solution was added 
until the pH value was 5. The mixture was washed with water (2 x 50 mL), followed by 
drying with anhydrous MgSO4, filtration and concentration in vacuo. The product 21 was 
purified by Kugelrohr distillation in 67% yield; 1H NMR (300 MHz, CDCl3) δ = 9.36 (s, 
1H), 2.31 – 2.19 (m, 2H), 1.83 - 1.79 (m, 2H), 1.05 (s, 6H). 
 
N
 
(Z)-4,4-dimethyl-6-phenyl-5-hexenenitrile (23a): To a solution of 
benzyltriphenylphophonium bromide 19 (4.97 g, 11.46 mmol) in 60 mL of THF at 0°C, 
n-BuLi (2.5 M in hexane solution, 4.6 mL, 11.46 mmol) was added dropwise. After 
stirring at 0°C for 1 h, nitrile aldehyde 21 (1.20 g, 9.55 mmol) was added to the solution. 
The resulting solution was stirred overnight at room temperature. Saturated NH4Cl 
solution was added to quench the reaction, followed by extraction with ethyl acetate. The 
desired nitrile product was isolated by flash column chromatography (silica gel, 
EtOAc:hexane 1:10 ), in 73% combined yield, and a cis:trans ratio of 6:1; 1H NMR (300 
MHz, CDCl3): δ = 7.37 – 7.21 (m, 3 H), 7.19 – 7.09 (m, 2 H), 6.58 (d, J = 12.7 Hz, 1 H), 
5.43 (d, J = 12.7 Hz, 1 H), 2.31 – 2.19 (m, 2 H), 1.71 – 1.59 (m, 2 H), 0.98 (s, 6 H). 
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(E)-4,4-dimethyl-6-phenyl-5-hexenenitrile (23b): Compound 23b was collected as a 
minor product of procedure of 23a. 1H NMR (300 MHz, CDCl3) δ = 7.41 – 7.22 (m, 5H), 
6.33 (d, J = 16.3 Hz, 1H), 6.07 (d, J = 16.3 Hz, 1H), 2.33 – 2.21 (m, 2H), 1.81 (m, 2H), 
1.15 (s, 6H). 
 
O
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Z-4,4-Dimethyl-6-phenyl-5-hexenoic acid (20): To a solution of nitrile 23a (0.40 g, 2 
mmol) in 10 mL of 4:1 ethanol and water, KOH (0.34 g, 6 mmol) was added in one 
portion. After the reaction mixture had been heated to reflux for 1 h, another portion of 
KOH (0.17, 3 mmol) was added. The reaction was kept boiling for another 24 h. A 1M 
HCl solution was added to the cooled reaction mixture until the pH=3. Extraction with 
ethyl acetate gave 0.42 g (85%) of acid; 1H NMR (300 MHz, CDCl3): δ= 7.34 – 7.11 (m, 
5H), 6.53 (d, J = 12.7 Hz, 1H), 5.46 (d, J = 12.7 Hz, 1H), 2.40 – 2.27 (m, 2H), 1.70 – 
1.57 (m, 2H), 0.94 (s, 6H). 
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Lactone (24): To a 2:1 acetone and H2O solution (20 mL) with acid 20 (0.22 g, 1 mmol) 
and of TMAO (0.45 g, 4 mmol), 0.63 mL of OsO4 in t-BuOH solution (2.5% wt. %) was 
added dropwise. The reaction was monitored by TLC until the starting material was gone. 
Saturated sodium sulfite solution was added, and the mixture was stirred for 30 min 
followed by extraction with dichloromethane. The resulting product was dissolved in 
dichloromethane, followed by 1 equivalent of DCC and 10 mol % of DMAP. The 
reaction mixture was stirred overnight, then washed with saturated NH4Cl solution, and 
brine. Flash column chromatography (silica gel, EtOAc:hexane 2:1 ) gave the desired 
lactone product in 52% yield; 1H NMR (300 MHz, CDCl3): δ = 7.47 – 7.24 (m, 5H), 4.81 
(t, J = 5.3 Hz, 1H), 4.30 (d, J = 5.7 Hz, 1H), 2.67 (d, J = 5.0 Hz, 1H), 2.44 (ddd, J = 11.8, 
8.1, 6.4 Hz, 2H), 1.65 (dt, J = 13.2, 8.1 Hz, 1H), 1.57 – 1.43 (m, 1H), 1.12 (s, 3H), 0.92 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ = 171.4, 141.1, 128.8, 128.6 127.7, 89.4, 74.6, 
35.6, 32.4, 27.6, 27.5, 20.9. 
 
O
 
(Z)-2,6,6-Trimethyl-8-phenyl-7-octen-3-one (27): The reaction mixture of carboxylic 
acid 20 (0.0867 g, 0.40 mmol) and thionyl chloride (0.058 mL, 0.8 mmol) in benzene 
solution was heated to reflux for 4 hr. When the temperature cooled down, the mixture 
was concentrated in vacuo. At – 78 °C, to the resulting mixture with CuI (0.1171 g, 0.62 
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mmol) in THF was added isopropylmagnesium chloride (2 M in THF solution, 0.226 ml, 
0.452mmol) dropwise. The reaction mixture was allowed to warm to room temperature 
and stir overnight. 1 M HCl aqueous solution was added to quench the reaction follow by 
extraction with EtOAc( 3 x 30 mL), drying with anhydrous MgSO4, filtration and 
concentration in vacuo to give crude product 27 in 94% yield without further purificaton; 
1H NMR (300 MHz, CDCl3) δ = 7.33 – 7.07 (m, 5H), 6.50 (d, J = 12.7 Hz, 1H), 5.46 (d, 
J = 12.7 Hz, 1H), 2.62 – 2.49 (m, 1H), 2.53 – 2.27 (m, 2H), 1.70 – 1.50 (m, 2H), 1.07 (dd, 
J = 7.3, 2.4 Hz, 6H), 0.94 (d, J = 2.8 Hz, 6H). 
 
O O
 
5-Isopropyl-2,2-dimethyl-7-phenyl-6,8-dioxabicyclooctane (26): Route A (from 
lactone 24): To a solution of 62 mg (0.26 mmol) of lactone in THF solution at  -78°C, 
0.33 mL (0.66 mmol) of isopropyl magnesium chloride solution (2 M in THF) was added 
dropwise. The reaction was stirred at -78°C for 5 h. Then saturated NH4Cl solution was 
added to quench the reaction, followed by extraction with ethyl acetate. Prep-TLC gave 
23 mg (33%) of product. 
 
Route B (from alkene 27): To a 2:1 acetone and H2O solution (5 mL) with ketone 27 
(0.091 g, 0.37 mmol) and of TMAO (0.083 g, 0.74 mmol), 0.23 mL of OsO4 in t-BuOH 
solution (2.5% wt. %) was added dropwise. The reaction was monitored by TLC until the 
starting material was gone. Saturated sodium sulfite solution was added, and the mixture 
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was stirred for 30 min followed by extraction with dichloromethane. The resulting 
product was dissolved in dichloromethane, and was allowed to stir with p-TsOH (5 mg) 
at room temperature for overnight. The resulting mixture was filtered and concentrated in 
vacuo. The product 26 was purified with flash column chromatography (silica gel, 
EtOAc:hexane 1:4 ) in 53% yield; 1H NMR (300 MHz, CDCl3): δ = 7.46 (d, J = 7.6 Hz, 
2H), 7.38 – 7.18 (m, 3H), 5.25 (d, J = 4.6 Hz, 1H), 4.03 (dd, J = 4.6, 1.9 Hz, 1H), 2.11 – 
1.66 (m, 4H), 1.21 – 1.13 (m, 1H), 1.11 – 1.00 (m, 9H), 0.17 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 137.8, 128.3, 127.2, 126.5, 111.3, 86.0, 81.5, 35.4, 34.6, 30.8, 28.5, 28.0, 26.1, 
17.1, 17.1. 
 
N
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(E)-4,4-Dimethyl-6-(4-methoxyphenyl)-5-hexenenitrile (29): To a solution of (4-
methoxybenzyl)triphenylphophonium bromide 28 (4.33 g, 10.3 mmol) in 60 mL of THF 
at 0°C, n-BuLi (2.5 M in hexane solution, 4.12 mL, 10.3 mmol) was added dropwise. 
After stirring at 0°C for 1 h, nitrile aldehyde 21 (1.1766 g, 9.4 mmol) was added to the 
solution. The resulting solution was stirred overnight at room temperature. Saturated 
NH4Cl solution was added to quench the reaction, followed by extraction with ethyl 
acetate. To the crude product (1.9649 g, 8.57 mmol) in 50 mL benzene solution was 
added AIBN (0.1407g, 0.857 mmol) and thiophenol (0.44 mL, 4.285 mmol). The 
resulting mixture was heated to reflux for 9 h. After evaporation of solvent, the mixture 
was purified with flash column chromatography (silica gel, EtOAc:hexane 1:10 ) to give 
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trans isomer 29 in 91% for 2 steps; 1H NMR (300 MHz, CDCl3) δ = 7.29 (d, J = 8.4 Hz, 
2H), 6.85 (d, J = 8.7 Hz, 2H), 6.26 (d, J = 16.2 Hz, 1H), 5.92 (d, J = 16.2 Hz, 1H), 3.81 
(s, 3H), 2.37 – 2.20 (m, 2H), 1.85 – 1.72 (m, 2H), 1.13 (s, 6H). 
 
O
O
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E-4,4-Dimethyl-6-(4-methoxyphenyl)-5-hexenoic acid (30): Acid 30 was prepared 
according to previous hydrolysis procedure of acid 20 in 94% yield.  
 
O
O
 
(E)-2,6,6-Trimethyl-8-(4-methoxyphenyl)-7-octen-3-one (31): Compound 31 was 
prepared according to previous procedure of ketone 27 in 95% yield; 1H NMR (300 MHz, 
CDCl3) δ 7.28 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 6.22 (d, J = 16.2 Hz, 1H), 
5.97 (d, J = 16.2 Hz, 1H), 3.80 (s, 3H), 2.57 (p, J = 7.0 Hz, 1H), 2.45 – 2.33 (m, 2H), 
1.65 (m, 2H), 1.15 – 1.00 (m, 12H). 
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5-Isopropyl-7-(4-methoxyphenyl)-2,2-dimethyl-6,8-dioxabicyclooctane (32): Analog 
32 was obtained according previous procedure for 26 (route B) in 61% yield; 1H NMR 
(300 MHz, CDCl3): δ 7.26 – 7.16 (m, 2H), 6.82 – 6.75 (m, 2H), 4.98 (br s, 1H), 3.72 (br 
s, 4H), 2.00 (p, J = 7.0 Hz, 1H), 1.68 (dd, J = 8.7, 2.0 Hz, 2H), 1.58 – 1.50 (m, 1H), 1.35 
– 1.28 (m, 1H), 1.05 – 0.94 (m, 9H), 0.91 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 159.2, 
135.5, 127.8, 113.9, 112.2, 90.1, 78.0, 55.5, 35.7, 32.8, 30.3, 26.4, 26.2, 24.6, 18.4, 17.8; 
HRMS (ESI-TOF) calcd for C18H26O3 [M + H]+ 291.1955, found 290.1882. 
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CHAPTER 3. 
TOTAL SYNTHESIS OF FUROMOLLUGIN* 
 
3.1. Introduction 
 
The roots of Rubia cordifolia L. (Rubiaceae) have been used in traditional 
Chinese medicine for centuries to treat joint inflammation, dysmenorrhea, hematorrhea, 
hemostasis, and psoriasis.1,2 They are officially listed in the Chinese Pharmacopoeia, 
which is an official compendium of drugs, covering traditional Chinese and western 
medicines. The methanol extract of the dried roots of R. cordifolia can be fractionated by 
partitioning first between chloroform and water, and then between n-butanol and water. 
Anthraquinone, naphtho-hydroquinone, naphthohydroquinone are some of the 
compounds that have been isolated using this method since the 1970s.3 Most of the 
isolated compounds contain the furonaphthalene subunit.  Specific natural products are 
shown in Figure 1 and include furomollugin (1), mollugin (2), and rubilactone (3).4-6   
The biological activities of these isolated compounds have been investigated after 
the antitumour activity of bicyclic hexapeptides, which were isolated from the extract of 
Rubia cordfolia, was reported by Itokawa and co-workers two decades ago.7 In 1996, the 
inhibition activity of furomollugin (1) and mollugin (2) against hepatitis B virus (HBV), 
which commonly results in chronic and acute hepatitis, was reported by Ho and 
coworkers.8 Compound 1 and 2 strongly suppressed the secretion of the hepatitis B 
                                                
* Adapted with permission from Kraus, G. A.; Dong, P., Nat. Prod. Commun. 2015, 10, 
1025-1026. Copyright © 2015 Natural Product Inc. 
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surface antigen, both with IC50 values of 2.0 µg/mL, in human hepatoma Hep3B cells 
while having little effect on the viability of the cells. Compound 2 is thought to be a 
Janus kinase 2 (JAK2) inhibitor and inhibits lipopolysaccharide (LPS)-induced 
inflammatory responses by blocking the activation of the Janus kinase/ signal transducers 
and activators of the transcription (JAK-STAT) pathway.9 According to the work 
conducted by Woo and co-workers, compound 1 showed weak cytotoxicity to a human 
colon carcinoma cell line (HT-29), possibility mediated through topoisomerase 
inhibition.10  
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Figure 1. Some isolated compounds. 
 
 Since the isolation of these compounds from R. cordifolia, scientists have been 
working to find effective synthetic routes to produce the natural compounds with unique 
structures and interesting biological activities. Among all these analogs, mollugin (2) is 
well investigated and several synthetic routes have been reported since it was first 
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isolated. Most of the reported methods utilized acid-catalyzed cyclization of methyl 1, 4-
dihydroxy-2-naphthoate and different reagents, including a very direct synthesis by De 
Kimpe, as shown in Scheme 1.11 In the route developed by De Kimpe, methyl 1,4-
dihydroxy-naphthalene-2-carboxylate was first prepared by esterification of the 
carboxylic acid 6 with diazomethane. Then the methyl ester was heated under reflux with 
3-methyl-3-buten-1-ol in tetrahydrofuran (THF) and boron trifluoride diethyl etherate 
(BF3-OEt2) to yield 3,4-dihydromollugin 4 via BF3-activation of the alcohol moiety by 
borate formation followed by subsequent ortho-alkylation of the aromatic alcohol and 
cyclization by attack of the phenol oxygen across the proton-activated carbon–carbon 
double bond of the isoprenyl group. Alternatively, the yield of the isolated 3,4-
dihydromollugin 4 can be increased to 84% by using formic acid instead of BF3-OEt2. In 
the last step, 3,4-dihydromollugin 4 was converted to the desired mollugin 2 by oxidation 
with dichlorodicyano-p-benzoquinone (DDQ) in dioxane in 22% yield. This yield can be 
increased to 81% by using a DDQ oxidation of dihydromollugin 4 in toluene.  
For furomollugin (1), there are also some reported methods. The first synthetic 
route was reported by Schildknecht and Straub in 1976, as seen in Scheme 2.12 They 
synthesized furomollugin (1) from 1,4-dihydroxy-2-naphthoic acid 7. The sulfuric acid 
catalyzed cyclization of compound 7 and glycolaldehyde formed acid 8. The selective 
esterification with diazomethane gave desired compound 1. This is the first reported 
synthesis of furmollugin 1. However, the overall yield of this method is really low, only 
2% from acid 7 to ester 1. 
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Scheme 1. Direct synthesis of 2 by De Kimpe. 
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Scheme 2. First synthesis of furomollugin (1) by Schildknecht and Straub. 
 
 In 2005, another synthetic route to furomollugin 1 was reported by Trauner and 
co-workers in Scheme 3.13 They started from 2-carbomethoxy- naphthoquinone 9, which 
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was prepared by Fischer esterification of 1,4-dihydroxynaphthoic acid 7, followed by 
oxidative demethylation, as exhibited in Scheme 3. Vinyl naphthohydroquinone 11 was 
prepared by conjugate addition of a vinyl cuprate derived from vinyl stannane 10 to 2-
carbomethoxynaphthoquinone 9, followed by tautomerization. Oxidation of 11 with 
aqueous cerium ammonium nitrate not only restored the quinone but also resulted in 
cleavage of the silyl ether to afford 12. Vinyl quinone 12 was not stable and underwent 
conversion into naphthofuran 14 in 23% yield and furomollugin (1) in 24% yield. This 
reaction presumably proceeds through cation 13, which undergoes either deprotonation to 
afford 14 or retro-Friedel-Crafts hydroxyalkylation to yield 1. In their synthesis towards 
5-hydroxybenzo[2,3-b]furan natural product rubicordifolin, furomollugin (1) could be 
produced as a minor byproduct in 36% yield. 
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Scheme 3. Synthesis of 1 by Trauner. 
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  In 2008, Trauner and co-workers improved their synthesis method to 
furomollugin (1) in a total synthesis route of rubicordifolin, as seen in Scheme 4.14 They 
made mollugin (2) from naphthoquinone 15, which was also prepared from naphthoic 
acid 7. Oxidation of 2 with cerium ammonium nitrate afforded 17, which was converted 
to compound 1 under basic conditions. This conversion presumably undergoes ring 
opening to form 18, then a five-member ring cyclization to provide 19, followed by 
expulsion of acetone to afford 1. 
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Scheme 4. Improved synthesis of 1 by Trauner.  
 
A direct synthesis of furomollugin (1) has been reported by Xia and Lee in 2013 
as exhibited in Scheme 5. They chose previously described 2-carbomethoxy- 
naphthoquinone 9 as the starting material. The cyclization reaction of 9 with ethyl vinyl 
ether utilizing ceric ammonium nitrate as a Lewis acid catalyst. This reaction proceeds 
through complex 21, followed by attack of vinyl ethyl ether to give another intermediate 
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22. Isomerization of 22 followed by intramolecular cyclization formed acetal 20. 
Treatment of 20 with acid eliminated ethanol to provide the natural product in excellent 
yield over two steps. 
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Scheme 5. Synthetic route of 1 by Xia and Lee. 
 
Moreover, a similar procedure was reported by Piggott in 2014, as illustrated in 
Scheme 6.16 The reaction of 9 with butyl vinyl ether gave acetal 24 in good yield. Then 
acid-catalyzed aromatization afforded furomollugin (1). The one-pot procedure beginning 
with toluene and then switching the solvent to MeOH before acidification gave 
compound 1 in a slightly better yield than the two-pot process. Additionally, De Kimpe 
and coworkers reported an innovative ring contraction sequence that converted the 
mollugin skeleton to an isopropenyl-substituted furomollugin,17 which was not covered 
here. 
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Scheme 6. Synthetic route of 1 by Pigrott. 
  
 Most of the reported synthetic routes started from 2-carbomethoxy-
naphthoquinone 9, which was derived from 1,4-dihydroxy-2-naphthoic acid 7. The 
preparation of 7 is shown in Scheme 7. Condensation of diethyl 3,6-dihydroxyphthalate 
25 and diethyl succinate 26 followed by acid-catalysed decarboxylation afforded 1,4-
dihydroxy-naphthalene-2-carboxylic acid 7. This three-step synthesis suffers from the 
disadvantage of a low overall yield. The variable yields of the double Claisen 
condensation are often as low as 5% and mounting to 48%, pointing to a tricky reaction.18 
Due to this drawback, we wanted to design a novel synthetic route toward 1. 
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Scheme 7. Preparation of naphthoic acid 7.  
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 The Hauser-Kraus annulation is a good way to generate naphthalene 
hydroquinones from phthalide anions and α, β–unsaturated carbonyl compounds.19, 20 The 
mechanism of the Hauser-Kraus annulation is shown in Scheme 8. Deprotection of the 
functionalized phthalide produced anion 31 followed by a Michael addition gives 
intermediate 32. Then 32 undergoes a bicyclic ring formation followed by expulsion of 
the ketone to form naphthoquinone 34. The desired product 35 is obtained after 
tautomerization. The feature of the Hauser-Kraus reactions is that four carbons of the 
newly formed cyclohexenone ring are supplied by the Michael acceptor.21 A number of 
natural products have been synthesized via the efficient addition of phthalides 29 and 30 
using a range of Michael acceptors.22  
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Scheme 8. Mechanism of the Hauser-Kraus annulation. 
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3.2. Results and Discussion 
 
 Our strategy for the synthesis of 1 involved the Hauser-Kraus annulation. The 
retrosynthetic analysis is depicted below in Scheme 9. The furan ring could be installed 
by an anion formation of the benzylic position of 36 follow by cyclization. Compound 36 
would be formed from phthalide 29 and methyl crotonate 37. And the functionalized 
phthalide 29 can be prepared based on the previous reported procedure.22 In principle, it 
offers a pathway to compounds 1 – 3 depending on the structure of R3 in ester 37.  
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Scheme 9. Retrosynthesis of 1. 
 
 To test our proposed route, we started to make the intermediate 36. Treatment of 
2-carboxybenzaldehyde 38 with thiophenol and para-toluenesulfonic acid (PTSA) 
afforded Phthalide 29 in 80% yield. Compound 36 was formed through the Hauser-Kraus 
annulation of 29 with methyl crotonate in 68% yield. During our work, we found that 
lithium tert-butoxide produced a cleaner reaction compared to potassium tert-butoxide. 
Additionally, we prepared some hydroxyl group protected naphthalene hydroquinones 
from 36. 
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Scheme 10. Synthesis of 36. 
 
 With compound 36 in hand, we tried to deprotonate the benzylic position of 36, as 
shown in Scheme 11. First, a tri-anion was made with a strong base from 36, then treated 
with ethyl formate or dimethylformamide (DMF). However, the deprotonation of 36 with 
3 equivalents of lithium diisopropylamide (LDA) or lithium tetramethylpiperidide 
(LiTMP) returned recovered starting material. Next we tried to protect two hydroxyl 
groups with formyl groups to give compound 40. We hypothesized that the formed anion 
on benzylic position would attack the closest carbonyl group to transfer the formyl group 
to the benzylic position. Unfortunately, the reaction didn’t happen as we expected, only 
the starting material was recovered. At last, we changed the protection group to benzyl 
group and methoxymethyl group to get compound 41 and 42. Again, the deprotonation of 
dibenzyl ether 41 or bis-MOM ether 42 with excess base (LDA, LiTMP) returned 
recovered starting material when treated with ethyl formate or DMF. While the rationale 
for our inability to acylate 36 or its ethers is not clear, we changed our synthetic plan as 
illustrated in Scheme 12. Instead of installing formyl group with the anion chemistry at 
the end, we used a Michael acceptor 43 with an acetal group which could be converted to 
aldehyde. 
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Scheme 11. Deprotonation of benzylic position.  
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Scheme 12. Alternate synthetic route to 1. 
 
 To test this new route, ethyl 3,3-diethoxypropionate 44 was reduced to aldehyde 
45 with diisobutylaluminium hydride (DIBAL) at -78 °C in 74% yield.23 The resulting 
aldehyde was converted to the ,-unsuturated acetal ester 43 by the Horner-Wadsworth-
Emmons reaction (HWE) with trimethyl phosphonoacetate 46 in 72% yield. The Hauser-
Kraus annulation with phthalide 29 and acetal ester 43 affored and furomollugin (1) in 
8% yield and compound 47 in 42% yield which could be converted into 1 using para-
toluenesulfonic acid. 
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Scheme 13. Synthesis of 1. 
 
3.3. Conclusions  
 
 Furomollugin (1) was isolated from the roots of Rubia cordifolia L. by 
Schildknecht and Straub in the 1970s. Since then, several synthetic routes towards this 
natural product have been reported. 1,4-Dihydroxynaphthoic acid 7 is a common starting 
material for these methods. A novel direct synthesis of 1 was achieved from 
commercially available materials. The key step of our synthetic route is the Hauser-Kraus 
annulation of functionalized phthalide 29 with a known acetal eter 43. This efficient route 
will enable the broad evaluation of the antiviral activity of this interesting natural product 
(1). Moreover, this novel synthetic route offers a new pathway to other compounds in R. 
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cordifolia family, such as mollugin (2), and rubilactone (3), depending on the structure of 
Michael acceptors.  
 
3.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich; THF was freshly distilled 
with LAH, other solvents were purchased from Fisher Scientific and used without further 
purification. All reactions were carried out in flame-dried glassware under argon with dry 
solvents under anhydrous conditions, unless specified. All yields refer to 
chromatographically isolated products. Reactions were monitored by thin layer 
chromatography (TLC) carried out on 0.20 mm silica gel plates using UV light as a 
visualizing agent and potassium permanganate with heat as developing agents. Silica gel 
60Å, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 
13C NMR spectra were acquired on a Varian VXR-300 or Bruker DRX-500 spectrometer. 
1H and 13C chemical shifts (δ) are given in ppm relative to the residual protonated solvent 
peak (CDCl3: δH = 7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC =49.0 ppm; 
(CD3)2SO: δH = 2.50 ppm, δC = 39.52 ppm; (CD3)2CO: δH = 2.05 ppm, δC = 29.84 ppm) 
as an internal reference. High resolution mass spectra (HRMS) were recorded on an 
Agilent 6540 QTOF (quadrupole time of flight) mass spectrometer using ESI 
(electrospray ionization) or APCI (atmospheric-pressure chemical ionization), or EI 
(electron ionization) on an Agilent 6890 GC/MS. 
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O
O
SPh  
Phthalide (29): To a flame-dried flask with 2-carboxybenzaldehyde 38 (1.6569 g, 11.04 
mmol) and PTSA (82.8 mg) in 50 ml benzene solution was added thiophenol (1.35 mL, 
13.24 mmol). The resulting mixture was heated up to reflux with the Dean-Stark 
apparatus setup for 3 h. After the solution was cooled down, the mixture was 
concentrated in vacuo. The recrystallization of the crude product with hexane and ethyl 
acetate gave phthalide 29 in 80% yield as a white solid; 1H NMR (300 MHz, CDCl3) δ = 
7.79 (d, J = 7.6 Hz, 1H), 7.77 – 7.61 (m, 3H), 7.53 – 7.48 (m, 3H), 7.33 – 7.20 (m, 2H), 
6.73 (s, 1H). 
 
OH
OH
O
O
 
Methyl 1,4-dihydroxy-3-methyl-2-naphthoate (36): To a stirred solution of tert-butanol 
(1.1389 g, 15.37 mmol) in THF (50 ml) at 0 °C under argon atmosphere was added n-
butyllithium (6.15 ml,15.37 mmol) and the mixture was allowed to stir at 0 °C for 30 min 
to get a lithium tert-butoxide solution. At -78°C, 10 ml of a THF solution of phthalide 29 
(1.2009 g, 4.96 mmol) was added slowly into the prepared lithium tert-butoxide solution. 
The mixture was stirred at -78 °C for another 30 minutes, after which methyl crotonate 
37 (0.7444 g, 7.43 mmol) was injected into the reaction mixture at -78 °C. The resulting 
mixture was stirred at -78 °C for 1 hr and then allowed to warm to room temperature to 
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sit overnight. The reaction was quenched with 4 M HCl solution followed by the 
extraction with ethyl acetate (3 x 60 mL). The organic layer was dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to give the crude product. The 
recrystallization with hexane and diethyl ether afforded 36 in 61% yield as a white solid; 
1H NMR (300 MHz, CDCl3) δ = 12.06 (s, 1H), 8.39 (d, J = 8.2 Hz, 1H), 8.05 (d, J = 8.3 
Hz, 1H), 7.70 – 7.58 (m, 1H), 7.56 – 7.44 (m, 1H), 4.71 (s, 1H), 4.01 (s, 3H), 2.54 (s, 
3H). 
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Methyl 1,4-bis(formyloxy)-3-methyl-2-naphthoate (40): To a solution of 36 (0.1131 g, 
0.49 mmol) in THF was added DIPEA (0.19 mL, 1.07 mmol) at 0 °C. The acetic formic 
anhydride was added after 5 minutes. The reaction was monitored by TLC. After no 
starting material was left, saturated NH4Cl solution was added to quench the reaction 
followed by extraction with ethyl acetate. The combined organic layer was dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to give the crude product. The 
residue was purified with flash column chromatography (silica gel, EtOAc:hexane 1:5 ) 
to give 40 in 85% yield; 1H NMR (300 MHz, CDCl3) δ = 8.49 (s, 1H), 8.40 (s, 1H), 7.92 
– 7.79 (m, 2H), 7.69 – 7.51 (m, 2H), 3.95 (s, 3H), 2.35 (s, 3H). 
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Methyl 1,4-bis(benzyloxy)-3-methyl-2-naphthoate (41): To an acetone solution of 36 
(0.3836 mg, 1.65 mmol) and potassium carbonate (1.1414 g, 8.26 mmol) was added 
benzyl bromide (0.98 mL, 8.26 mmol). The resulting mixture was heated to 60 °C for 
reaction. After 48 h, the solution was cooled down followed by filtration and 
concentration in vacuo. The residue was extracted with water and ethyl acetate (3 X 30 
mL). The combined organic layer was dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to give the crude product, which was purified with flash column 
chromatography (silica gel, EtOAc:hexane 1:5 ) to give 41  in 65% yield; 1H NMR (300 
MHz, CDCl3) δ = 8.17 – 8.08 (m, 2H), 7.62 – 7.31 (m, 12H), 5.14 (s, 2H), 4.98 (s, 2H), 
3.91 (s, 3H), 2.41 (s, 3H). 
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Methyl 1,4-bis(methoxymethoxy)-3-methyl-2-naphthoate (42): Compound 42 was 
prepared according to the previous procedure of compound 40.; 1H NMR (300 MHz, 
CDCl3) δ = 8.10 (dd, J = 11.1, 8.4 Hz, 2H), 7.53 (t, J = 8.6 Hz, 2H), 5.13 (d, J = 14.3 Hz, 
4H), 3.97 (s, 3H), 3.67 (s, 3H), 3.62 (s, 3H), 2.40 (s, 3H). 
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3,3-Diethoxypropanal (44): To a solution of methyl 3,3-diethoxypropanoate 44 (1.9113 
g, 10.05 mmol) in anhydrous dichloromethane (5 mL) was added a solution of DIBAL 
(78.8 mL of a 1.0 M solution in toluene, 15.75 mmol) over 20 minutes at -78 °C. After 
addition, the reaction was stirred at -78 °C for an additional 45 minutes after which 
methanol (0.3 mL) was added. The reaction was then warmed to room temperature and 
stirred for 30 minutes. To the reaction was sequentially added water (~5 mL), stirred 10 
minutes, and then solid Na2SO4. Upon stirring for 10 minutes the reaction mixture was 
filtered and concentrated in vacuo. The residue was purified with flash column 
chromatography (silica gel, Et2O:pentane 1:5 ) to give 44 in 74% yield as a colorless oil; 
1H NMR (300 MHz, CDCl3) δ = 9.75 (t, J = 2.3 Hz, 1H), 4.96 (t, J = 5.5 Hz, 1H), 3.61 
(ddq, J = 40.7, 9.3, 7.1 Hz, 4H), 2.73 (dd, J = 5.5, 2.3 Hz, 2H), 1.21 (t, J = 7.0 Hz, 6H). 
 
O
OMeOEt
EtO  
Methyl (E)-5,5-diethoxypent-2-enoate (43): Into a flame dried flask with a stir bar was 
placed sodium hydride (0.2175 g, 5.43 mmol) and 20 ml dry THF and the slurry is cooled 
to 0 °C. Trimethyl phosphonoacetate (1.0598 g, 5.82 mmol) is then added dropwise and 
the mixture warmed to room temperature and stirred for 30 min. Compound 44 (0.6975 g, 
4.77 mmol) was then added as a solution in 5 ml THF. After stirring for 30 minutes, the 
reaction was quenched with saturated aqueous NH4Cl solution and extracted with EtOAc. 
(3 x 50 mL) The combined organic layer was dried over Na2SO4, filtered and 
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concentrated in vacuo. The residue was purified with flash column chromatography 
(silica gel, EtOAc:hexane 1:20) to give 43 in 72% yield as a light yellow oil; 1H NMR 
(300 MHz, CDCl3) δ = 6.93 (dt, J = 15.1, 7.2 Hz, 1H), 5.98 – 5.85 (m, 1H), 4.58 (t, J = 
5.6 Hz, 1H), 3.73 (s, 3H), 3.71 – 3.56 (m, 2H), 3.56 – 3.45 (m, 2H), 2.53 (ddd, J = 7.2, 
5.5, 1.6 Hz, 2H), 1.21 (t, J = 7.0 Hz, 6H). 
 
OH O
O
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Furomollugin (1): To a stirred solution of tert-butanol (0.30 g, 4.1 mmol) in THF (5 ml) 
at 0 °C under argon atmosphere was added n-butyllithium (1.64 ml, 4.1 mmol) and the 
mixture was allowed to stir at 0 °C for 30 min to get a lithium tert-butoxide solution. At -
78°C, 2 ml of a THF solution of phthalide 29 (0.33 g, 1.36 mmol) was added slowly into 
the prepared lithium tert-butoxide solution. The mixture was stirred for another 30 min at 
-78 °C, after which the acetal ester 43 (0.41 g, 2.0 mmol) was injected into the reaction 
mixture at -78 °C. The resulting mixture was stirred at -78 °C for 1 hr and then allowed to 
warm to room temperature to sit overnight. The reaction was quenched with 4 M HCl 
solution followed by the extraction with ethyl acetate. The organic layer was dried over 
MgSO4 and evaporated to give crude product, which was purified by flash column 
chromatography on silica gel to give 47 in 42% yield and 1 in 6% yield. The 8 was 
converted to 1 by refluxing in toluene with PTSA in 93% yield; 1H NMR (400 MHz, 
CDCl3) δ = 12.27 (1H, s), 8.47 (1H, d, J = 8.4 Hz), 8.20 (1H, d, J = 8.3 Hz), 7.82 – 7.67 
(2H, m), 7.60 – 7.48 (1H, m), 7.19 (1H, d, J = 2.2 Hz), 4.08 (3H, s); 13C NMR (101 MHz, 
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CDCl3) δ 172.0, 159.0, 144.4, 144.3, 130.1, 125.1, 124.9, 124.9, 122.9, 119.8, 119.7, 
109.3, 99.2, 52.3.; HRMS (ESI-TOF) calcd for C14H11O4 [M + H]+ 243.0652, found 
243.0658.  
 
OH O
O
O
OEt  
Methyl 2-ethoxy-5-hydroxy-2,3-dihydronaphtho[1,2-b]furan-4-carboxylate (47): 1H 
NMR (300 MHz, CDCl3) δ = 11.81 (s, 1H), 8.37 (d, J = 8.5 Hz, 1H), 7.92 (d, J = 8.3 Hz, 
1H), 7.61 (t, J = 7.5 Hz, 1H), 7.49 (t, J = 7.7 Hz, 1H), 5.87 (dd, J = 6.7, 2.5 Hz, 1H), 4.09 
– 3.97 (m, 1H), 3.96 (s, 3H), 3.77 – 3.57 (m, 2H), 3.51 – 3.38 (m, 1H), 1.26 (t, J = 7.0 Hz, 
3H). 
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CHAPTER 4. 
SUZUKI-MIYAURA REACTIONS OF ARYL HALIDES USING SUPPORTED 
PALLADIUM NANOPARTICLES 
 
4.1. Introduction 
 
Transition-metal compounds are extremely useful as catalysts for organic 
transformations which involve the construction of complex organic molecules such as 
pharmaceutical derivatives, natural products, and molecular materials.1 Among many 
transition metals used for organic synthesis, palladium catalysts and reagents are 
particularly useful and versatile.2 There are several features regarding palladium catalysts 
and reagents listed below. Most importantly, palladium catalysts offer an abundance of 
possibilities for carbon–carbon bond formation. No other transition metals can offer such 
versatile methods of the carbon–carbon bond formations as palladium. In 2010, the Noble 
prize was awarded to Heck, Negishi, and Suzuki for the development of palladium-
catalyzed cross-coupling reactions in organic synthesis.3 The Heck reaction,4 the Suzuki-
Miyaura reaction,5 the Negishi coupling reaction,6 and the Sonogashira reaction7 are now 
among the most commonly used organometallic reactions in both industry and academia. 
Organopalladium reactions have been employed in a number of complex natural product 
syntheses as well as pharmaceutical syntheses.8 In addition, valuable organopalladium 
reactions developed by Trost,9 Tsuji,10 Stille,11 Kumada,12 and Larock13 occupy a 
significant place in the “palladium toolbox”, as shown in Figure 1. 
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Figure 1. Palladium toolbox. 
 
The second important feature of palladium catalysts and reagents is the tolerance 
with a variety of functional groups such as carbonyl and hydroxyl groups. Palladium-
catalyzed reactions can be carried out with these functional groups smoothly. Although 
reactions involving palladium should be carried out carefully, palladium catalysts are not 
very sensitive to oxygen and moisture. Moreover, the toxicity of palladium has caused no 
serious problem so far. A number of industrial processes, particularly for the production 
of fine chemicals based on palladium-catalyzed reactions, have been developed and are 
currently being utilized. This fact reflects the advantages of using palladium catalysts 
commercially.2 
Although homogeneous catalysts are suitable in small scale applications, the 
evolution to heterogeneous palladium catalysts has become a rapidly emerging area of 
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research.14 Heterogeneous palladium catalysts are easy to recycle and separate from the 
product mixture. Additionally, there are opportunities to adjust the catalyst through 
variation in types of supports. Significantly, this approach avoids the need for expensive 
ligands. A number of solid materials, such as graphene,15 titania,16 polymers,17 metal 
organic frameworks (MOFs),18 mesoporous carbon,19 and magnetic nanoparticles20 have 
been employed as supports for palladium. Bimetallic catalysts have been devised, which 
in certain cases facilitate the separation of the catalyst.21 
The heterogeneous palladium catalyst developed by Datye and coworkers is 
convenient to prepare from the reaction of palladium acetate with methanol at ambient 
temperature.22 Additionally, the method of preparation is very flexible with regard to 
catalyst support, since the support is simply added as the reaction proceeds. Moreover, 
the particle size is 1.5 nm and no additional functionalization is required. 
The Datye catalyst was initially evaluated in the Suzuki-Miyaura reaction. The 
Suzuki-Miyaura reaction is one of the most important and powerful synthetic methods for 
the construction of carbon-carbon bonds, in particular for the formation of unsymmetrical 
biaryls.23 This reaction involves the palladium-mediated coupling of aryl boronic acids or 
their corresponding esters 1 with aryl halides 2. The mechanism of this reaction is shown 
in Figure 2.24 The first step is the oxidative addition of palladium catalyst 4 to the halide 
2 to form the organopalladium species 5. The treatment with bases gives intermediate 6, 
which is converted to intermediate 7 after transmetalation with boron-ate complex 8. 
Reductive elimination of the desired product 3 restores the original palladium catalyst 4 
which completes the catalytic cycle.  
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Figure 2. Mechanism of the Suzuki-Miyaura reaction. 
 
Almost every reported palladium catalyst affords high yields of coupling products 
with aryl iodides or aryl bromides, but the yields with aryl chlorides are frequently much 
lower. However, the use of aryl chlorides is desirable because they are inexpensive and 
readily available from a practical point of view. Furthermore, most of the reported 
coupling reactions were carried out in organic solvents. From a sustainable chemistry 
viewpoint, water is cheap, nontoxic, and readily available green reaction medium for 
organic synthesis. Therefore, the development of heterogeneous catalysts that can 
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activate aryl chlorides and facilitate the coupling reactions of aryl chlorides in aqueous 
media is highly desirable. 
A number of researchers have reported nanoparticle-mediated reactions of 
boronic acids with aryl halides. Liu and coworkers generated palladium nanoparticles in 
situ in PEG400 under aerobic conditions. Using 2 mole percent of palladium at 45 °C in 
PEG400, they achieved high yields of Suzuki coupling products with aryl chlorides and 
phenylboronic acid, as shown in Scheme 1(a).25 Jiang and coworkers stabilized palladium 
nanoparticles on a metal-organic framework (MIL-101). Reaction of this catalyst at 80 °C 
in water with aryl chlorides provided coupling products in high yields, as seen in Scheme 
1(b).26 Yang and coworkers synthesized silica nanoparticles functionalized with N-
heterocyclic carbenes.  Using 0.3 mole percent palladium at 80 °C, they achieved very 
good yields of products from aryl chlorides, as shown in Scheme 1(c).27 Li and coworkers 
prepared palladium-containing micelles stabilized by guanidinium ionic liquids (GIL5). 
Using 2 mole percent palladium at 100 °C afforded good to excellent yields (41% to 
99%) of products from aryl chlorides, as exhibited in Scheme 1(d).28 Ohtaka and 
coworkers recently reported linear polystyrene supported palladium catalysts that 
functioned as homogeneous catalysts in solution. Using this “catch-release” strategy they 
obtained very good yields of products from aryl chlorides and bromides, as shown in 
Scheme 1(e).29 In Scheme 1(f), Liu and coworkers used an aqueous DMF solution and 
palladium catalysts at 100 °C and reported good to very good yields of Suzuki products 
with aryl chlorides.30 
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Scheme 1. Reported nanoparticle-mediated reactions. 
 
Although utilizing most of these reported catalysts afforded high yields for the 
Suzuki-Miyaura reaction of boronic acids and aryl chlorides, none of the nanoparticle 
preparation protocols compared to the Datye catalyst in terms of operational convenience. 
Moreover, only a few of the catalyst systems described above achieved the goal of green 
chemistry to use water as the solvent for reactions. We utilized the Datye catalyst to find 
the best aqueous catalyst system for the Suzuki-Miyaura coupling of boronic acids and 
aryl chlorides. 
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4.2. Results and Discussion 
 
To test the possibility of using the Datye catalyst for the Suzuki-Miyaura reaction, 
we first compared the catalytic ability of this supported palladium on carbon nanoparticle 
catalyst (5 wt%) with commercially available palladium on carbon catalyst, which was 
purchased from Kawaken Fine Chemicals (10 wt%, 53.5% water content). Using 0.2 
mole percent of the Datye catalyst with tetrabutylammonium bromide and sodium 
hydroxide at 100 °C in water produced the desired coupling product in 38% yield from 
4’-chloro-acetophenone and phenylboronic acid, as shown in Table 1, Entry 2.31 This 
yield was higher than the yield of the coupling reaction catalyzed with the commercially 
available palladium on carbon catalyst (Table 1, Entry 1). Furthermore, reaction of 4-
chloroanisole at 100 °C in water with 2 mole percent of Datye catalyst loading afforded 
the desired coupling product in 42% yield, comparing to 34% yield with the catalyst 
purchased from Kawaken (Table 1, Entry 3-4). 
 The comparison test in Table 1 shows that the Datye catalyst is a better palladium 
catalyst for the Suzuki-Miyaura reaction in aqueous solution than the commercial 
catalyst. Moreover, the Datye catalyst requires a lower catalyst loading for the reaction 
compared to other reported catalysts. To further demonstrate the utility of this palladium 
catalyst for the Suzuki reaction, a number of aryl chlorides were reacted with 
representative commercially available boronic acids, which is shown in Table 2. We 
found that increasing the reaction time from two hours to 12 hours increased the reaction 
yield of 4’-chloro-acetophenone and phenylboronic acid to 72% from 38%, as seen in 
Table 2, Entry 1. Some other aryl chlorides were used for the Suzuki reaction with 
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phenylboronic acid and the Datye catalyst, as exhibited in Table 2, Entry 2-4. Using 
electron deficient aryl chlorides, such as methyl 2-chlorobenzate and methyl 4-
chlorobenzoate, gave the desired coupling products 11 in 20% yield and 12 in 22% yield. 
Increasing the reaction time of electron efficient aryl chloride 4-chloroanisole did not 
increase the reaction yield, which was 42%.  
 
Table 1. Comparison of catalytic activity. 
Cl
R
+
B(OH)2
R
 Pd/C
TBAB (0.5 equiv.)
NaOH (5 equiv.)
H2O, 100 °C  
Entry R Pd/C source Pd/C (%) 
Time 
(h) 
Yield 
(%) 
1a Ac Kawaken 0.2 2 27 
2a Ac Datye 0.2 2 38 
3 OMe Kawaken 0.2 6 34 
4 OMe Datye 0.2 6 42 
a. 2.5 equiv. NaOH was used. 
 
Since 4’-chloroacetophenone gave us the best yield among these aryl chlorides 
described above, we used this compound for the Datye catalyst catalyzed Suzuki reaction 
with a variety of boronic acids, as seen in Table 2, Entry 5-7. Using 4-methoxy-
phenylboronic acid produced the product in a 45% yield at 100 °C in water, as seen in 
Table 2, Entry 5. The Suzuki reaction of 4-acetylphenylboronic acid with 4’-
chloroacetophenone catalyzed with the Datye catalyst only gave 9% yield with 0.2 mole 
percent catalyst loading (Table 2, Entry 6). The yield was increased to 25% (based on 
NMR spectra) with 2 mole percent catalyst loading (Table 2, Entry 7).  
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Table 2. Suzuki-Miyaura reaction of aryl chlorides catalyzed with the Datye catalyst. 
 
Entry R1 R2 
Pd 
(%) 
Time 
(h) 
Boronic 
acid 
(equiv) 
NaOH 
(equiv) Product 
Yield 
(%) 
1 H 4-Ac 0.2 12 1.1 2.5 
O
10
 
72 
2 H 2-CO2Me 0.2 12 1.1 2.5a 
O
O
11
 
20 
3 H 4- CO2Me 0.2 12 1.1 2.5a 
O
O
12  
22 
4 H 4-OMe 2 12 1.5 5 
O 13
 
42 
5 4-OMe 4-Ac 0.2 2 1.1 2.5 
O
O 14
 
45 
6 4-Ac 4-Ac 0.2 2 1.1 2.5 
O
O
15
 
9 
7 4-Ac 4-Ac 2 2 1.1 2.5 
O
O
15
 
25 
a. The KF was used as base. 
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The Datye catalyst prepared by the Datye group consists of small, highly 
dispersed 1-3 nm palladium particles, as depicted in Figure 3. The size and shape of the  
palladium nanoparticle catalyst was determined by Datye group by using a high angle 
annular dark field (HAADF) scanning transmission electron microscopy (STEM) after 
the catalytic experiments, as illustrated in Figure 4. Although the utility of this palladium  
nanoparticle catalyst for the Suzuki coupling in water media was proven, the sintering of 
palladium particles was observed after reaction with aryl chlorides. In Figure 4(a) and 
4(b), the spent catalyst sample from reaction of 4’-chloroacetophenone and 4-
methoxyphenylboronic acid in dimethylformamide (DMF) shows significant sintering of 
palladium particles (over 20 nm) when the reaction was performed using 
dimethylformamide as the solvent. In contrast, the spent sample in Figure 4(c) shows less 
sintering of palladium particles when the reaction was performed using water as the 
solvent. Figures 4(c) and 4(d) appear to show a bimodal distribution, with palladium 
particles over 20 nm (d) and palladium particles between 1-3 nm (c).  
 
 
(a) (b)
 
Figure 3. HAADF-STEM images at low (a) and high (b) 
magnifications of the Datye catalyst. 
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 To further test the activity of catalyst, coupling reactions of aryl bromides with 
boronic acids were carried out, as shown in Table 2. The reaction of 4-bromotoluene and 
phenylboronic acid with 0.2 mole percent of the Datye catalyst, tetrabutylammonium 
bromide and sodium hydroxide at 100 °C in water produced the desired product 16 in 
90% yield after column chromatography separation, as seen in Table 3, Entry 1. This 
result indicated that the Datye catalyst exhibits excellent catalytic activity for the Suzuki 
reaction of aryl bromides. Using 3-bromotoluene in the same condition afforded 
compound 17 in 89% yield, as shown in Table 3, Entry 2. In Table 3, Entry 3, utilizing 
1,3-dibromobenzene with 2.2 equivalent of phenylboronic acid gave m-terphenyl 18 in 
49% yield. 
 
 
 
 
(h)(g)
(a) (b)
(c) (d)
 
Figure 4. HAADF-STEM images of the sample (a,b) after reaction in DMF, 
and the sample (c,d) after reaction in water. 
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Table 3. Suzuki-Miyaura reaction of aryl bromides catalyzed with the Datye catalyst. 
B(OH)2
R1
+
Br
R2
0.2mol% Pd/C
TBAB (0.5 equiv.)
NaOH
H2O
100ºC R1
R2
 
Entry R1 R2 
Pd 
(%) 
Time 
(h) 
Boronic 
acid 
(equiv) 
NaOH 
(equiv) Prodct 
Yield 
(%) 
1 H 4-Me 0.2 12 1.1 2.5 
16  
90 
2 H 3-Me 0.2 12 1.1 2.5 
17  
89 
3 H 3-Br 0.2 12 2.2 2.5 
18  
49 
 
 After the catalytic experiment 
of aryl bromides, the catalyst was 
collected to check the size and shape 
by HAADF-STEM. The images are 
shown in Figure 5. All the spent 
samples from the Suzuki reaction of 
aryl bromides show a significant 
reduction in sintering of palladium, 
compared to the samples from reaction 
of aryl chloride. The size of a recycled 
pallidum nanoparticle catalyst is 
around 5 nm after reaction according 
(f)(e)
Low Magnification High Magnification
(a) (b)
(c) (d)
 
Figure 5. HAADF-STEM images at low 
(left) and high (right) magnifications of the 
samples from Table 3: Entry 1 (a, b); Entry 2 
(e,f); Entry 3 (c, d). 
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to the HAADF-STEM images. This is not a significant change when compared to the size 
of the as-prepared catalyst, which is 1.5 nm.  
 The low yield of the catalyzed Suzuki-Miyaura reaction of aryl chlorides may be 
explained by the size change of particles during reactions. The sintering of palladium 
nanoparticles, when the reactions were performed with aryl chlorides, decreased the 
catalytic activity of the Datye catalyst. In contrast, a change in size of particles was not 
observed when reactions were performed with aryl bromide. The Datye catalyst can give 
a high yield of desired coupling product from aryl bromides. 
Br
+
B(OH)2
0.2 mol%  Pd/C
TBAB (0.5 equiv.)
NaOH (5 equiv.)
H2O, 100 °C  
 
Figure 6. Recyclability test of the Datye catalyst.  
The condition for each run: phenylboronic acid (0.1341 g, 1.1 mmol), 4-bromo toluene (0.1710 g, 1.0 
mmol), tertbutylammonium bromide (0.1612 g, 0.5 mmol), sodium hydroxide (0.1 g, 2.5 mmol), 
catalyst (5 wt% Pd/C, 0.0043 g, 2.0 µmmol, recycled), water (5 mL), temperature: 100 °C, time: 
overnight. 
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 Because the Datye catalyst was recovered intact in the reaction with aryl 
bromides, the recyclability of this catalyst can be studied. The reaction of 4-bromotoluene 
and phenylboronic acid with 0.2 mole percent palladium catalyst loading was carried out 
for the test, as shown in Figure 6. After three recycles, the catalyst was still active and the 
product yield was 80%, compared with 90% for first run. As the catalyst can be recycled 
for three consecutive runs in water, the Dayte catalyst represents a sustainable variant of 
palladium catalyzed coupling chemistry. Inductively Coupled Plasma Mass Spectrometry 
(ICP-MS) analysis revealed that only 0.3% of palladium species leached into the solution, 
which indicated that the Datye catalyst is a heterogeneous catalyst as expected.  
 
4.3. Conclusions  
  
The Datye catalyst can be used as a heterogeneous catalyst for the Suzuki-
Miyaura reaction of aryl chlorides and boronic acids in water. The low reaction yields of 
aryl chlorides was presumably caused by the sintering of palladium particles. This 
catalyst also showed an excellent activity for the coupling reactions of aryl bromides. 
Even after several recycles, the activity was not decreased. There was no sintering 
observed when the reactions were performed with aryl bromides. In addition, the 
preparation of this palladium nanoparticle catalyst is really simple compared with other 
reported catalysts. Excellent catalytic activity, simple preparation and environmentally 
friendly conditions, are all features that make the Datye catalyst a good candidate for 
palladium catalysts in industry.  
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4.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich. All yields refer to chromato-
graphically isolated products. Reactions were monitored by thin layer chromatography 
(TLC) carried out on 0.20 mm silica gel plates using UV light as a visualizing agent and 
potassium permanganate with heat as developing agents. Silica gel 60Å, particle size 
0.032 – 0.063 mm, was used for flash column chromatography. 1H spectra were acquired 
on a Varian 400 MR or Bruker DRX-500 spectrometer. 1H chemical shifts (δ) are given 
in ppm relative to the residual protonated solvent peak (CDCl3: δH = 7.26 ppm) as an 
internal reference. Recycled samples were dispersed in ethanol and mounted on holey 
carbon grids for examination in a JEOL 2010F 200 kV transmission electron microscope. 
Images were recorded in high angle annular dark field (HAADF) mode. 
 
Selected Experimental, Physical, and Spectral Data 
The preparation of the Datye catalyst: The catalyst was prepared by the Datye group. 
A solution of Pd acetate in methanol was ultrasonicated for 40 min to completely dissolve 
the Pd acetate, and the solution was added to Vulcan carbon XC-72 to obtain a Pd 
loading of 5 wt%.  A Buchi rotary evaporator was used to gently remove methanol from 
the sample at 40 °C , and the dried product was collected. 
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4-Acetylbiphenyl (10): The preparation of 10 is representative. To a sealed tube, 
phenylboronic acid (0.1341 g, 1.1 mmol) and 4-chloroacetophenone (0.1456 g, 1.0 
mmol) was added into a 5 ml water solution with tertbutylammonium bromide (0.1619 g, 
0.5 mmol) and sodium hydroxide (0.1000 g, 2.5 mmol). After the Datye catalyst (0.0043 
g, 0.2 mol%) was added, the reaction mixture was heated to reflux for 12 hours. After the 
reaction was cooled down to room temperature, the solution was transferred to a 
centrifuge tube. 10 mL of methylene chloride was then added followed by 5 min 
centrifuge. Then the clear organic layers were transferred to a separatory funnel, followed 
by washing with water (2 x 5 mL), drying with anhydrous MgSO4, filtration and 
concentration in vacuo. The desired product 1 was purified by flash column 
chromatography (silica gel, EtOAc:hexane 1:10 ), in 72% yield as a white solid; 1H NMR 
(400 MHz, CDCl3) δ = 8.07 – 8.00 (m, 2H), 7.73 – 7.59 (m, 4H), 7.52 – 7.38 (m, 3H), 
2.64 (s, 3H). 
 
O
O
 
Methyl biphenyl-2-carboxylate (11): KF was used as a base instead of NaOH. The yield 
is based on NMR. 1H NMR data was identical to corresponding literature NMR spectra.32 
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Methyl biphenyl-4-carboxylate (12): KF was used as a base instead of NaOH. 1H NMR 
(400 MHz, CDCl3): δ = 8.15 – 8.07 (m, 2H), 7.71 – 7.59 (m, 4H), 7.49 – 7.44 (m, 2H), 
7.42 – 7.36 (m, 1H), 3.95 (s, 3H). 
 
 
O  
4-Methoxybiphenyl (13): 1H NMR (400 MHz, CDCl3): δ = 7.54 – 7.44 (m, 4H), 7.42 – 
7.35 (m, 2H), 7.28 – 7.23 (m, 1H), 6.98 (d, J = 8.3 Hz, 2H), 3.86 (s, 3H). 
 
O
O  
1-(4'-Methoxybiphenyl-4-yl)ethanone (14): 1H NMR (400 MHz, CDCl3) δ = 8.02 - 
7.98 (m, 2H), 7.66 - 7.61 (m, 2H), 7.59 - 7.54 (m, 2H), 7.02 - 6.97 (m, 2H), 3.85 (s, 3H), 
2.62 (s, 3H). 
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4,4'-Diacetylbiphenyl (15): 1H NMR (500 MHz, CDCl3) δ = 8.06 – 8.07 (m, 4H); 7.72 – 
7.73 (m, 4H), 2.66 (s, 6H). 
 
 
4-Methylbiphenyl (16): 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.56 (m, 2H), 7.54 – 7.40 
(m, 4H), 7.40 – 7.28 (m, 1H), 7.29 – 7.22 (m, 2H), 2.41 (s, 3H). 
 
 
3-Methylbiphenyl (17): 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.54 (m, 2H), 7.48 – 7.37 
(m, 4H), 7.32 (td, J = 7.5, 2.1 Hz, 2H), 7.15 (d, J = 7.5 Hz, 1H), 2.41 (s, 3H). 
 
 
m-Terphenyl (18): 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 2.0 Hz, 1H), 7.69 (d, J = 
7.6 Hz, 4H), 7.63 – 7.60 (m, 2H), 7.57 – 7.46 (m, 5H), 7.41 (t, J = 7.4 Hz, 2H). 
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CHAPTER 5. 
GENERAL CONCLUSIONS 
 
 In the first chapter, several small molecule inhibitors towards Porcine 
reproductive and respiratory syndrome virus (PRRSV) were developed. Natural 1-(E)- 
Atractylodinol was successfully synthesized in seven steps, which showed 100% 
inactivation of PRRSV in in vitro test. This is the first synthetic route towards 1-(E)- 
Atractylodinol. Based on the structure of 1-(E)- Atractylodinol, more than fifteen analogs 
were designed and synthesized. Among all the synthesized analogs, nine of them showed 
more than 90 percent virus netralization. Specifically, one dimethyl amino analog is the 
most cost efficient product to synthesize in order to make animal testing feasible in the 
near future. 
 Chapter 2 focused on developing a synthetic approach to the psoracorylifols. The 
unique 6,8-dioxabicyclo[3.2.1]octane skeleton can be formed concisely by utilizing ketal 
formation as a key step. The overall yield is 40% in 5 steps. This route will enable the 
analysis of psoracorylifols in order to better understand the mechanism of action of this 
novel family of natural products. 
 Chapter 3 describes a novel direct synthetic route towards furomollugin. The 
method constructs furomollugin from commercially available materials via the Hauser-
Kraus annulation of a functionalized phthalide and a Michael acceptor. This synthetic 
route will enable a broad evaluation of the biological activities of furomollugin and offer 
a new pathway towards other compounds in this family.  
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 The last chapter discusses the utility of the Datye catalyst for the Suzuki-Miyaura 
reaction of aryl chlorides in aqueous solution. As a novel heterogeneous catalyst, the 
Datye catalyst has several advanced features compared to other palladium catalysts, such 
as excellent catalytic activity, simple preparation and environmentally friendly 
conditions. All these features will make the Datye catalyst a great substantial palladium 
catalyst in industry. 
  
 
